Exploring the Chemistry and Applications of Thio-, Seleno-, and Tellurosugars

Academic Editors: Francesca Cardona and Macarena Martínez-Bailén Received: 1 March 2025 Revised: 28 April 2025 Accepted: 28 April 2025 Published: 5 May 2025 Citation: Martínez-Pascual, R.; Valera-Zaragoza, M.; FernándezBolaños, J.G.; López, Ó. Exploring the Chemistry and Applications of Thio-, Seleno-, and Tellurosugars. Molecules 2025,30, 2053. https://doi.org/ 10.3390/molecules30092053 Copyright: © 2025 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/ licenses/by/4.0/). Review Exploring the Chemistry and Applications of Thio-, Seleno-, and Tellurosugars Roxana Martínez-Pascual 1, Mario Valera-Zaragoza 1, José G. Fernández-Bolaños 2and Óscar López 2,* 1Centro de Investigaciones Científicas, Instituto de Química Aplicada, Universidad del Papaloapan, Circuito Central 200, Col. Parque Industrial, Tuxtepec 68301, Oaxaca, Mexico; [email protected] (R.M.-P.); [email protected] (M.V.-Z.) 2Departamento de Química Orgánica, Facultad de Química, Universidad de Sevilla, Apartado 1203, E-41071 Seville, Spain; [email protected] *Correspondence: [email protected] Abstract: Given the crucial roles of carbohydrates in energy supply, biochemical processes, signaling events and the pathogenesis of several diseases, the development of carbohydrate analogues, called glycomimetics, is a key research area in Glycobiology, Pharmacology, and Medicinal Chemistry. Among the many structural transformations explored, the replacement of endoand exocyclic oxygen atoms by carbon (carbasugars) or heteroatoms, such as nitrogen (azaand iminosugars), phosphorous (phosphasugars), sulfur (thiosugars), selenium (selenosugars) or tellurium (tellurosugars) have garnered significant attention. These isosteric substitutions can modulate the carbohydrate bioavailability, stability, and bioactivity, while introducing new properties, such as redox activity, interactions with pathological lectins and enzymes, or cytotoxic effects. In this manuscript we have focused on three major families of glycomimetics: thio-, seleno-, and tellurosugars. We provide a comprehensive review of the most relevant synthetic pathways leading to substitutions primarily at the endocyclic and glycosidic positions. The scope includes metal-catalyzed reactions, organocatalysis, electroand photochemical transformations, free-radical processes, and automated syntheses. Additionally, mechanistic insights, stereoselectivity, and biological properties are also discussed. The structural diversity and promising bioactivities of these glycomimetics underscore their significance in this research area. Keywords: glycomimetics; thiosugars; selenosugars; tellurosugars; thioglycosides; selenoglycosides 1. Introduction Carbohydrates are ubiquitous biomolecules with essential biological functions across all domains of life. Beyond serving as a primary energy source and storage form, they play crucial structural roles (e.g., cellulose, chitin), and act as key building blocks in anabolic pathways, including nucleic acids biosynthesis [ 1 ]. Complex carbohydrates (glycans) [ 1 ] are also integral components of glycoconjugates such as glycolipids and glycoproteins, which are embedded in cell membranes and participate in critical signaling events, both endogenous and pathogen-mediated. Moreover, carbohydrates serve as templates for the development of novel therapeutics [ 1 ] targeting metabolic disorders [ 2 ], cancer (e.g., carbohydrate-based vaccines) [ 3 ], infectious diseases [4], and drug delivery systems, including nanocarriers [5]. Given their immense biological significance, carbohydrate analogues, referred to as glycomimetics, have emerged as a promising research area, offering deeper insights into Molecules 2025,30, 2053 https://doi.org/10.3390/molecules30092053 Molecules 2025,30, 2053 2 of 54 carbohydrate interactions, modulating bioactivity, and even introducing novel properties. Among the vast array of synthetic modifications applicable to carbohydrate structures, bioisosteric replacements of oxygen and carbon atoms deserve attention. The substitution of the endocyclic oxygen, or the anomeric carbon with carbon (carbasugars) [ 6 ], nitrogen (iminosugars) [ 7 ], phosphorous (phosphasugars) [ 8 ], sulfur (thiosugars) [ 9 ], selenium (selenosugars) [ 10 ] and tellurium (tellurosugars) [ 11 ] (Figure 1) has led to the development of an arsenal of compounds that have expanded the frontiers of Glycobiology research, and constitute some of the most relevant glycomimetics. Molecules 2025, 30, x FOR PEER REVIEW 2 of 58 Given their immense biological significance, carbohydrate analogues, referred to as glycomimetics, have emerged as a promising research area, offering deeper insights into carbohydrate interactions, modulating bioactivity, and even introducing novel properties. Among the vast array of synthetic modifications applicable to carbohydrate structures, bioisosteric replacements of oxygen and carbon atoms deserve attention. The substitution of the endocyclic oxygen, or the anomeric carbon with carbon (carbasugars) [6], nitrogen (iminosugars) [7], phosphorous (phosphasugars) [8], sulfur (thiosugars) [9], selenium (selenosugars) [10] and tellurium (tellurosugars) [11] (Figure 1) has led to the development of an arsenal of compounds that have expanded the frontiers of Glycobiology research, and constitute some of the most relevant glycomimetics. Figure 1. General structure of relevant glycomimetics. In this review, we will discuss recent advances in the development of chalcogen-containing glycomimetics and their implication in Glycoscience. 2. S-Containing Carbohydrates Thiosugars represent a vast family of glycoconjugates in which either a hydroxyl group or the endocyclic oxygen is replaced by sulfur. This isosteric substitution induces significant conformational and physico-chemical changes in the sugar mimic. Due to its bigger atomic radius, sulfur forms longer C‒S bonds compared to oxygen, resulting in smaller dihedral angles [12]. Additionally, sulfur has smaller electronegativity and a more hydrophobic character, while not exhibiting hydrogen bonding acceptance capacity, which affects water solubility [13]; the stronger sulfur-π interactions between thiosugars and lectins compared to oxygen can be useful in the design of effective drugs [14]. Many thiosugars exhibit substantially improved hydrolytic or enzymatic stability compared to their oxygencontaining counterparts, which is undoubtedly advantageous for the design of new drugs [9]. There are some examples found in nature, like 5-thio-D-mannose, thioglycosides (e.g., glucosinolates) and 1,4-thioanhydrosugars (e.g., kotalanol, salacinol, Figure 2) [15]. Figure 2. Structure of salacinol and kotalanol. Figure 1. General structure of relevant glycomimetics. In this review, we will discuss recent advances in the development of chalcogencontaining glycomimetics and their implication in Glycoscience. 2. S-Containing Carbohydrates Thiosugars represent a vast family of glycoconjugates in which either a hydroxyl group or the endocyclic oxygen is replaced by sulfur. This isosteric substitution induces significant conformational and physico-chemical changes in the sugar mimic. Due to its bigger atomic radius, sulfur forms longer C–S bonds compared to oxygen, resulting in smaller dihedral angles [ 12 ]. Additionally, sulfur has smaller electronegativity and a more hydrophobic character, while not exhibiting hydrogen bonding acceptance capacity, which affects water solubility [ 13 ]; the stronger sulfurπ interactions between thiosugars and lectins compared to oxygen can be useful in the design of effective drugs [ 14 ]. Many thiosugars exhibit substantially improved hydrolytic or enzymatic stability compared to their oxygen-containing counterparts, which is undoubtedly advantageous for the design of new drugs [ 9 ]. There are some examples found in nature, like 5-thio-D-mannose, thioglycosides (e.g., glucosinolates) and 1,4-thioanhydrosugars (e.g., kotalanol, salacinol, Figure 2) [15]. Molecules 2025, 30, x FOR PEER REVIEW 2 of 58 Given their immense biological significance, carbohydrate analogues, referred to as glycomimetics, have emerged as a promising research area, offering deeper insights into carbohydrate interactions, modulating bioactivity, and even introducing novel properties. Among the vast array of synthetic modifications applicable to carbohydrate structures, bioisosteric replacements of oxygen and carbon atoms deserve attention. The substitution of the endocyclic oxygen, or the anomeric carbon with carbon (carbasugars) [6], nitrogen (iminosugars) [7], phosphorous (phosphasugars) [8], sulfur (thiosugars) [9], selenium (selenosugars) [10] and tellurium (tellurosugars) [11] (Figure 1) has led to the development of an arsenal of compounds that have expanded the frontiers of Glycobiology research, and constitute some of the most relevant glycomimetics. Figure 1. General structure of relevant glycomimetics. In this review, we will discuss recent advances in the development of chalcogen-containing glycomimetics and their implication in Glycoscience. 2. S-Containing Carbohydrates Thiosugars represent a vast family of glycoconjugates in which either a hydroxyl group or the endocyclic oxygen is replaced by sulfur. This isosteric substitution induces significant conformational and physico-chemical changes in the sugar mimic. Due to its bigger atomic radius, sulfur forms longer C‒S bonds compared to oxygen, resulting in smaller dihedral angles [12]. Additionally, sulfur has smaller electronegativity and a more hydrophobic character, while not exhibiting hydrogen bonding acceptance capacity, which affects water solubility [13]; the stronger sulfur-π interactions between thiosugars and lectins compared to oxygen can be useful in the design of effective drugs [14]. Many thiosugars exhibit substantially improved hydrolytic or enzymatic stability compared to their oxygencontaining counterparts, which is undoubtedly advantageous for the design of new drugs [9]. There are some examples found in nature, like 5-thio-D-mannose, thioglycosides (e.g., glucosinolates) and 1,4-thioanhydrosugars (e.g., kotalanol, salacinol, Figure 2) [15]. Figure 2. Structure of salacinol and kotalanol. Figure 2. Structure of salacinol and kotalanol. 2.1. 4′- and 5′-Thiosugars Classical synthetic approaches for introducing a sulfur atom into a ring to give thiosugars have been recently reviewed [ 16 ]; one of the most successful approaches involves Molecules 2025,30, 2053 3 of 54 the introduction of a leaving group at the appropriate position of the sugar, and reaction with a sulfur-containing nucleophile. Herein, recent syntheses of thiosugars with practical interest will be reviewed. Ueda and co-workers reported [ 17 ] the preparation of the sucrose analogues (+)- 5-thiosucrose (5) and (+)-5-thioisosucrose (6) as potential sweeteners and glycosidase inhibitors. The key step of the synthesis was a stereoselective glycosylation reaction between a D-psicose or a D-fructose donor, respectively, and a 5-thio-D-glucose derivative (1and 3) as acceptors (Scheme 1). Due to the strong anomeric effect induced by 1and 3, they acted as α -directing glycosyl acceptors. Unfortunately, none of the compounds displayed appreciable activity as sweeteners or inhibitors [17]. Molecules 2025, 30, x FOR PEER REVIEW 3 of 58 2.1. 4′- and 5′-Thiosugars Classical synthetic approaches for introducing a sulfur atom into a ring to give thiosugars have been recently reviewed [16]; one of the most successful approaches involves the introduction of a leaving group at the appropriate position of the sugar, and reaction with a sulfur-containing nucleophile. Herein, recent syntheses of thiosugars with practical interest will be reviewed. Ueda and co-workers reported [17] the preparation of the sucrose analogues (+)-5thiosucrose (5) and (+)-5-thioisosucrose (6) as potential sweeteners and glycosidase inhibitors. The key step of the synthesis was a stereoselective glycosylation reaction between a D-psicose or a D-fructose donor, respectively, and a 5-thio-D-glucose derivative (1 and 3) as acceptors (Scheme 1). Due to the strong anomeric effect induced by 1 and 3, they acted as α-directing glycosyl acceptors. Unfortunately, none of the compounds displayed appreciable activity as sweeteners or inhibitors [17]. Scheme 1. Retrosynthetic analysis for the preparation of (+)-5-thiososucrose (5) and (+)-5-thioisosucrose (6). Díaz-Fernández and Pino-González reported [18] a simple approach for the synthesis of the thiomonosaccharide 10 from D-mannose. The synthesis involved the use of di-Oisopropylidene D-mannose 7, which was transformed into the diastereomeric E/Z mixture of oxime 8 using hydroxylamine hydrochloride under basic conditions. The hydroxyl groups of 8 were subsequently mesylated to produce compound 9. Finally, the mesylate group underwent an SN2 substitution reaction with Na2S, followed by intramolecular cyclization on the nitrile group, yielding the thiosugar 10 (Scheme 2). Scheme 1. Retrosynthetic analysis for the preparation of (+)-5-thiososucrose (5) and (+)-5thioisosucrose (6). Díaz-Fernández and Pino-González reported [ 18 ] a simple approach for the synthesis of the thiomonosaccharide 10 from D-mannose. The synthesis involved the use of di-Oisopropylidene D-mannose 7, which was transformed into the diastereomeric E/Zmixture of oxime 8using hydroxylamine hydrochloride under basic conditions. The hydroxyl groups of 8were subsequently mesylated to produce compound 9. Finally, the mesylate group underwent an S N 2 substitution reaction with Na 2 S, followed by intramolecular cyclization on the nitrile group, yielding the thiosugar 10 (Scheme 2). Molecules 2025, 30, x FOR PEER REVIEW 4 of 58 Scheme 2. Synthesis of thiomonosaccharide 10. Reagents and conditions: (a) NH2OH·HCl, NaHCO3; (b) MsCl, 0 °C→r.t.; (c) Na2S·9H2O, DMF Liu and coworkers explored [19] the preparation of S-linked uronates (12–15) using a thiolation reaction (PhSH, BnSH) under alkaline and radical-mediated conditions on Δ4,5-unsaturated methyl uronate 11 (Scheme 3). The reaction demonstrated to be inefficient under radical conditions, which was attributed to the electron-withdrawing effect of the ester moiety located on C-5, although it proceeded with good regioand stereoselectivity at C-4 and C-5 positions. Under basic conditions, good stereoselectivity was obtained at C-4, but, conversely, poor stereoselectivity at C-5, tentatively due to a retro thiol-Michael reaction. Attempts to obtain a S-linked pseudodisaccharide failed as, unexpectedly, when 13 was treated with a Lewis acid (AlCl3) to remove the benzyl group, the thiofuranoside 16 was obtained serendipitously (Scheme 3). Scheme 3. Synthesis of S-linked uronate derivatives and formation of the thiofuronoside 16. Reagents and conditions: (a) PhSH, BnSH; (b) BnSH, thermal/photo-inititator; c) AlCl3, toluene, 48 h. A family of thiosugars that has gained considerable attention is the sulfonium-containing carbohydrates, as they are analogues of the naturally occurring kotalanol and salacinol (Figure 2), both isolated from Salacia reticulata extracts, and known to be potent inhibitors of intestinal glycosidases [20]. These sulfonium glycomimetics are therefore promising candidates for the treatment of diabetes [21]. In this context, Takashima et al. hypothesized [22] that the incorporation of a hydrophobic moiety into the side chain of salacinol could enhance its inhibitory activity against glycosidases through favorable van der Waals interactions. To test this hypothesis, derivatives 19‒24 were prepared (Scheme 4), the alkylation of O-protected thiosugar 17 using cyclic sulfates 18 being the key step. The final compounds were evaluated as inhibitors of rat maltase, sucrose and isomaltase, as well as human maltase. While no clear effects of the hydrocarbon residue were observed on maltase or isomaltase inhibition, sucrose inhibition displayed a length-dependent inhibitory activity, with longer appendages yielding the most potent compounds (IC50 = 0.15‒0.73 µM for 19–22, 1.4 and 0.38 µM for 23 and 24). This resulted in an up to ten-fold increase in activity compared to parent salacinol [22]. Scheme 2. Synthesis of thiomonosaccharide 10. Reagents and conditions: (a) NH 2 OH · HCl, NaHCO 3 ; (b) MsCl, 0 ◦C→r.t.; (c) Na2S·9H2O, DMF. Liu and coworkers explored [ 19 ] the preparation of S-linked uronates (12–15) using a thiolation reaction (PhSH, BnSH) under alkaline and radical-mediated conditions on Molecules 2025,30, 2053 4 of 54 ∆4,5 -unsaturated methyl uronate 11 (Scheme 3). The reaction demonstrated to be inefficient under radical conditions, which was attributed to the electron-withdrawing effect of the ester moiety located on C-5, although it proceeded with good regioand stereoselectivity at C-4 and C-5 positions. Under basic conditions, good stereoselectivity was obtained at C-4, but, conversely, poor stereoselectivity at C-5, tentatively due to a retro thiol-Michael reaction. Attempts to obtain a S-linked pseudodisaccharide failed as, unexpectedly, when 13 was treated with a Lewis acid (AlCl 3 ) to remove the benzyl group, the thiofuranoside 16 was obtained serendipitously (Scheme 3). Molecules 2025, 30, x FOR PEER REVIEW 4 of 58 Scheme 2. Synthesis of thiomonosaccharide 10. Reagents and conditions: (a) NH2OH·HCl, NaHCO3; (b) MsCl, 0 °C→r.t.; (c) Na2S·9H2O, DMF Liu and coworkers explored [19] the preparation of S-linked uronates (12–15) using a thiolation reaction (PhSH, BnSH) under alkaline and radical-mediated conditions on Δ4,5-unsaturated methyl uronate 11 (Scheme 3). The reaction demonstrated to be inefficient under radical conditions, which was attributed to the electron-withdrawing effect of the ester moiety located on C-5, although it proceeded with good regioand stereoselectivity at C-4 and C-5 positions. Under basic conditions, good stereoselectivity was obtained at C-4, but, conversely, poor stereoselectivity at C-5, tentatively due to a retro thiol-Michael reaction. Attempts to obtain a S-linked pseudodisaccharide failed as, unexpectedly, when 13 was treated with a Lewis acid (AlCl3) to remove the benzyl group, the thiofuranoside 16 was obtained serendipitously (Scheme 3). Scheme 3. Synthesis of S-linked uronate derivatives and formation of the thiofuronoside 16. Reagents and conditions: (a) PhSH, BnSH; (b) BnSH, thermal/photo-inititator; c) AlCl3, toluene, 48 h. A family of thiosugars that has gained considerable attention is the sulfonium-containing carbohydrates, as they are analogues of the naturally occurring kotalanol and salacinol (Figure 2), both isolated from Salacia reticulata extracts, and known to be potent inhibitors of intestinal glycosidases [20]. These sulfonium glycomimetics are therefore promising candidates for the treatment of diabetes [21]. In this context, Takashima et al. hypothesized [22] that the incorporation of a hydrophobic moiety into the side chain of salacinol could enhance its inhibitory activity against glycosidases through favorable van der Waals interactions. To test this hypothesis, derivatives 19‒24 were prepared (Scheme 4), the alkylation of O-protected thiosugar 17 using cyclic sulfates 18 being the key step. The final compounds were evaluated as inhibitors of rat maltase, sucrose and isomaltase, as well as human maltase. While no clear effects of the hydrocarbon residue were observed on maltase or isomaltase inhibition, sucrose inhibition displayed a length-dependent inhibitory activity, with longer appendages yielding the most potent compounds (IC50 = 0.15‒0.73 µM for 19–22, 1.4 and 0.38 µM for 23 and 24). This resulted in an up to ten-fold increase in activity compared to parent salacinol [22]. Scheme 3. Synthesis of S-linked uronate derivatives and formation of the thiofuronoside 16. Reagents and conditions: (a) PhSH, BnSH; (b) BnSH, thermal/photo-inititator; (c) AlCl3, toluene, 48 h. A family of thiosugars that has gained considerable attention is the sulfoniumcontaining carbohydrates, as they are analogues of the naturally occurring kotalanol and salacinol (Figure 2), both isolated from Salacia reticulata extracts, and known to be potent inhibitors of intestinal glycosidases [ 20 ]. These sulfonium glycomimetics are therefore promising candidates for the treatment of diabetes [21]. In this context, Takashima et al. hypothesized [ 22 ] that the incorporation of a hydrophobic moiety into the side chain of salacinol could enhance its inhibitory activity against glycosidases through favorable van der Waals interactions. To test this hypothesis, derivatives 19–24 were prepared (Scheme 4), the alkylation of O-protected thiosugar 17 using cyclic sulfates 18 being the key step. The final compounds were evaluated as inhibitors of rat maltase, sucrose and isomaltase, as well as human maltase. While no clear effects of the hydrocarbon residue were observed on maltase or isomaltase inhibition, sucrose inhibition displayed a length-dependent inhibitory activity, with longer appendages yielding the most potent compounds (IC 50 = 0.15–0.73 µ M for 19–22, 1.4 and 0.38 µ M for 23 and 24). This resulted in an up to ten-fold increase in activity compared to parent salacinol [ 22 ]. Additionally, de-O-sulfonated analogues at C-3 ′ position (23 and 24) exhibited significantly stronger inhibition against isomaltase than 19–22, regardless of the hydrocarbon residue length. With the aim of evaluating whether the 5-membered thiosugar is essential for the α -glucosidase inhibitory activity exhibited by sulfonium-based thiosugars, Tanabe et al. recently synthesized [ 23 ] ring-cleaved salacinol analogues (25–28) and truncated salacinol analogues (29–31) (Figure 3). This investigation was prompted by a previous report [ 24 ] demonstrating that some acyclic analogues derived from 1-deoxynojirimycin, a potent α -glucosidase inhibitor, retained activity, indicating that the five-membered ring may not be crucial for the inhibitory effect. The results for the ring-cleaved salacinol analogues revealed that these compounds were inactive, highlighting the essential role of the 5-membered thiosugar in their potent activity. Molecules 2025,30, 2053 5 of 54 Molecules 2025, 30, x FOR PEER REVIEW 5 of 58 Additionally, de-O-sulfonated analogues at C-3′ position (23 and 24) exhibited significantly stronger inhibition against isomaltase than 19–22, regardless of the hydrocarbon residue length. Scheme 4. Preparation of salacinol derivatives with an elongated side chain. With the aim of evaluating whether the 5-membered thiosugar is essential for the αglucosidase inhibitory activity exhibited by sulfonium-based thiosugars, Tanabe et al. recently synthesized [23] ring-cleaved salacinol analogues (25–28) and truncated salacinol analogues (29–31) (Figure 3). This investigation was prompted by a previous report [24] demonstrating that some acyclic analogues derived from 1-deoxynojirimycin, a potent αglucosidase inhibitor, retained activity, indicating that the five-membered ring may not be crucial for the inhibitory effect. The results for the ring-cleaved salacinol analogues revealed that these compounds were inactive, highlighting the essential role of the 5-membered thiosugar in their potent activity. Figure 3. Ring-cleaved salacinol analogues. A frequent drawback found in the synthesis of sulfonium thiosugars as potential antidiabetic agents is the limited diastereoselectivity found in the alkylation reaction on the sulfur atom, hampering the scale-up of the process. Tanabe et al. reported [25] the alkylation of O-protected thiosugars with epoxides in hexafluoroisopropanol (HFIP), yielding a roughly 90% diastereomeric ratio (~26:1 α/β), which constitutes a 3-fold improvement compared to conventional methodologies. The excellent diastereoselectivity found was attributed to a cooperative mechanism composed of reversible S-alkylation and thermal isomerization. Using this methodology, derivatives 32 (Figure 4) were accessed and tested Scheme 4. Preparation of salacinol derivatives with an elongated side chain. Molecules 2025, 30, x FOR PEER REVIEW 5 of 58 Additionally, de-O-sulfonated analogues at C-3′ position (23 and 24) exhibited significantly stronger inhibition against isomaltase than 19–22, regardless of the hydrocarbon residue length. Scheme 4. Preparation of salacinol derivatives with an elongated side chain. With the aim of evaluating whether the 5-membered thiosugar is essential for the αglucosidase inhibitory activity exhibited by sulfonium-based thiosugars, Tanabe et al. recently synthesized [23] ring-cleaved salacinol analogues (25–28) and truncated salacinol analogues (29–31) (Figure 3). This investigation was prompted by a previous report [24] demonstrating that some acyclic analogues derived from 1-deoxynojirimycin, a potent αglucosidase inhibitor, retained activity, indicating that the five-membered ring may not be crucial for the inhibitory effect. The results for the ring-cleaved salacinol analogues revealed that these compounds were inactive, highlighting the essential role of the 5-membered thiosugar in their potent activity. Figure 3. Ring-cleaved salacinol analogues. A frequent drawback found in the synthesis of sulfonium thiosugars as potential antidiabetic agents is the limited diastereoselectivity found in the alkylation reaction on the sulfur atom, hampering the scale-up of the process. Tanabe et al. reported [25] the alkylation of O-protected thiosugars with epoxides in hexafluoroisopropanol (HFIP), yielding a roughly 90% diastereomeric ratio (~26:1 α/β), which constitutes a 3-fold improvement compared to conventional methodologies. The excellent diastereoselectivity found was attributed to a cooperative mechanism composed of reversible S-alkylation and thermal isomerization. Using this methodology, derivatives 32 (Figure 4) were accessed and tested Figure 3. Ring-cleaved salacinol analogues. A frequent drawback found in the synthesis of sulfonium thiosugars as potential antidiabetic agents is the limited diastereoselectivity found in the alkylation reaction on the sulfur atom, hampering the scale-up of the process. Tanabe et al. reported [ 25 ] the alkylation of O-protected thiosugars with epoxides in hexafluoroisopropanol (HFIP), yielding a roughly 90% diastereomeric ratio (~26:1 α / β ), which constitutes a 3-fold improvement compared to conventional methodologies. The excellent diastereoselectivity found was attributed to a cooperative mechanism composed of reversible S-alkylation and thermal isomerization. Using this methodology, derivatives 32 (Figure 4) were accessed and tested against human intestinal maltase. Those isomers with an ortho-substitution pattern exhibited strong inhibitory properties (IC 50 = 0.11–0.58 µ M). In vivo assays in mice revealed a high capacity for suppression of blood glucose, comparable to the antidiabetic drug voblibose [25]. Molecules 2025, 30, x FOR PEER REVIEW 6 of 58 against human intestinal maltase. Those isomers with an ortho-substitution pattern exhibited strong inhibitory properties (IC50 = 0.11‒0.58 µM). In vivo assays in mice revealed a high capacity for suppression of blood glucose, comparable to the antidiabetic drug voblibose [25]. Figure 4. Salacinol analogues with strong α-glucosidase inhibition. 2.2. Thioglycosides Thioglycosides are one of the most popular glycosyl donors in glycosylation reactions, widely used in the synthesis of oligosaccharides to furnish 1,2-cisand trans-linkages [26]. O-glycosides have also been obtained [27] in a stereoselective fashion starting from 1-mercapto-carbohydrates by reaction with an acid and a Cu or Co catalyst (Cu(acac)2, Co(acac)2), Ag2CO3 as the oxidant agent, and under microwave irradiation. As aforementioned, thioglycosides exhibit a considerably higher stability towards acidic and enzymatic hydrolysis compared to natural glycosidic linkages; this feature is important for increasing their bioavailability when incorporated in bioactive compounds. For instance, Banisalman et al. prepared [28] glycopeptides 33 by conjugating monoand disaccharides to the cysteine residues of the peptide through a disulfide linkage, involving the glycosidic position of the carbohydrate residue (Figure 5). Figure 5. General structure of disulfide-linked glycopeptides. Incorporation of S-linked Manα1→2Man termini into oligomannose glycans (Man3, Man4) led to complete stability towards enzymatic hydrolysis mediated by Xanthomonas manihotis mannosidase [29]. 1-S-α-Galp(1 → 3)-β-Galp motif was incorporated [30] into oligosaccharides, leading to the isosteric unit of the epitope recognized by lytic antibodies in T. cruzi, the parasitic agent responsible for the Chagas disease. An ample variety of thioglycosides have been reported as antiplasmodial [31] and antiviral agents [32], inhibitors of bacterial glycan biosynthesis [33], metabolic decoys of glycosylation [34], or heparanase inhibitors [35], among others; the latter ones are S-linked polysaccharides obtained via chemoenzymatic synthesis (heparosan synthase). Coumarin S-glycosides, obtained by thioglycoligase-mediated connection of 7-mercapto-4-methylcoumarins and p-nitrophenyl-D-glycopyranosides were claimed [36] to be potentially useful in bioimaging, due to their enhanced fluorescence emission properties compared to the parent coumarin. A relevant example of the improvement of biological activity achieved by isosteric oxygen-sulfur substitution at the glycosidic position was recently reported by Gademann and coworkers [37]. The authors enhanced the acid stability of the natural glycosylated Figure 4. Salacinol analogues with strong α-glucosidase inhibition. Molecules 2025,30, 2053 6 of 54 2.2. Thioglycosides Thioglycosides are one of the most popular glycosyl donors in glycosylation reactions, widely used in the synthesis of oligosaccharides to furnish 1,2-cisand translinkages [ 26 ]. O-glycosides have also been obtained [ 27 ] in a stereoselective fashion starting from 1-mercapto-carbohydrates by reaction with an acid and a Cu or Co catalyst (Cu(acac) 2 , Co(acac)2), Ag2CO3as the oxidant agent, and under microwave irradiation. As aforementioned, thioglycosides exhibit a considerably higher stability towards acidic and enzymatic hydrolysis compared to natural glycosidic linkages; this feature is important for increasing their bioavailability when incorporated in bioactive compounds. For instance, Banisalman et al. prepared [ 28 ] glycopeptides 33 by conjugating monoand disaccharides to the cysteine residues of the peptide through a disulfide linkage, involving the glycosidic position of the carbohydrate residue (Figure 5). Molecules 2025, 30, x FOR PEER REVIEW 6 of 58 against human intestinal maltase. Those isomers with an ortho-substitution pattern exhibited strong inhibitory properties (IC50 = 0.11‒0.58 µM). In vivo assays in mice revealed a high capacity for suppression of blood glucose, comparable to the antidiabetic drug voblibose [25]. Figure 4. Salacinol analogues with strong α-glucosidase inhibition. 2.2. Thioglycosides Thioglycosides are one of the most popular glycosyl donors in glycosylation reactions, widely used in the synthesis of oligosaccharides to furnish 1,2-cisand trans-linkages [26]. O-glycosides have also been obtained [27] in a stereoselective fashion starting from 1-mercapto-carbohydrates by reaction with an acid and a Cu or Co catalyst (Cu(acac)2, Co(acac)2), Ag2CO3 as the oxidant agent, and under microwave irradiation. As aforementioned, thioglycosides exhibit a considerably higher stability towards acidic and enzymatic hydrolysis compared to natural glycosidic linkages; this feature is important for increasing their bioavailability when incorporated in bioactive compounds. For instance, Banisalman et al. prepared [28] glycopeptides 33 by conjugating monoand disaccharides to the cysteine residues of the peptide through a disulfide linkage, involving the glycosidic position of the carbohydrate residue (Figure 5). Figure 5. General structure of disulfide-linked glycopeptides. Incorporation of S-linked Manα1→2Man termini into oligomannose glycans (Man3, Man4) led to complete stability towards enzymatic hydrolysis mediated by Xanthomonas manihotis mannosidase [29]. 1-S-α-Galp(1 → 3)-β-Galp motif was incorporated [30] into oligosaccharides, leading to the isosteric unit of the epitope recognized by lytic antibodies in T. cruzi, the parasitic agent responsible for the Chagas disease. An ample variety of thioglycosides have been reported as antiplasmodial [31] and antiviral agents [32], inhibitors of bacterial glycan biosynthesis [33], metabolic decoys of glycosylation [34], or heparanase inhibitors [35], among others; the latter ones are S-linked polysaccharides obtained via chemoenzymatic synthesis (heparosan synthase). Coumarin S-glycosides, obtained by thioglycoligase-mediated connection of 7-mercapto-4-methylcoumarins and p-nitrophenyl-D-glycopyranosides were claimed [36] to be potentially useful in bioimaging, due to their enhanced fluorescence emission properties compared to the parent coumarin. A relevant example of the improvement of biological activity achieved by isosteric oxygen-sulfur substitution at the glycosidic position was recently reported by Gademann and coworkers [37]. The authors enhanced the acid stability of the natural glycosylated Figure 5. General structure of disulfide-linked glycopeptides. Incorporation of S-linked Man α 1 → 2Man termini into oligomannose glycans (Man3, Man4) led to complete stability towards enzymatic hydrolysis mediated by Xanthomonas manihotis mannosidase [ 29 ]. 1-Sα -Galp(1 → 3)- β -Galp motif was incorporated [ 30 ] into oligosaccharides, leading to the isosteric unit of the epitope recognized by lytic antibodies in T. cruzi, the parasitic agent responsible for the Chagas disease. An ample variety of thioglycosides have been reported as antiplasmodial [ 31 ] and antiviral agents [ 32 ], inhibitors of bacterial glycan biosynthesis [ 33 ], metabolic decoys of glycosylation [ 34 ], or heparanase inhibitors [ 35 ], among others; the latter ones are S-linked polysaccharides obtained via chemoenzymatic synthesis (heparosan synthase). Coumarin S-glycosides, obtained by thioglycoligase-mediated connection of 7-mercapto-4methylcoumarins and p-nitrophenyl-D-glycopyranosides were claimed [ 36 ] to be potentially useful in bioimaging, due to their enhanced fluorescence emission properties compared to the parent coumarin. A relevant example of the improvement of biological activity achieved by isosteric oxygen-sulfur substitution at the glycosidic position was recently reported by Gademann and coworkers [ 37 ]. The authors enhanced the acid stability of the natural glycosylated macrolactone Fidaxomicin (Fdx), approved for the Clostridioides difficile (C. diff.) infections; the authors replaced the O-glycosidic bond by the corresponding thioglycoside. Although the natural compound has shown promising activities against other pathogenic agents, its clinical use in other pathogens rather than C. diff. is hampered by its limited acid stability, making it difficult to treat, for example, stomach infections. Treatment of Fdx with Cu(ClO 4 ) · 6H 2 O as catalyst and the corresponding O-protected-1-mercapto carbohydrate, furnished a mixture of three regioisomeric glycosylated products (modest yields) at C-11 (<5%), C-13 (10%) and C-15 (24%) positions, with conserved β -configuration. Figure 6 displays the structure of the thio-isoster of Fdx, obtained as a minor compound. Degradation studies in methanolic HCl revealed that, whereas Fdx underwent degradation (t1/2 = 62.7 min), S-Fdx was stable over a period of 540 min [ 37 ]. Additionally, although the substitution slightly reduced the antibacterial activity, S-Fdx retained potent efficacy against C. diff. (Minimum inhibitory concentrations (MIC) ranges of 0.12–4 µ g/mL) and Clostridium perfringens (MIC ranges of 0.06–0.5 µ g/mL). Regioisomeric thioglycosides at C-13 and C-15 positions demonstrated to be inactive. Molecules 2025,30, 2053 7 of 54 Molecules 2025, 30, x FOR PEER REVIEW 7 of 58 macrolactone Fidaxomicin (Fdx), approved for the Clostridioides difficile (C. diff.) infections; the authors replaced the O-glycosidic bond by the corresponding thioglycoside. Although the natural compound has shown promising activities against other pathogenic agents, its clinical use in other pathogens rather than C. diff. is hampered by its limited acid stability, making it difficult to treat, for example, stomach infections. Treatment of Fdx with Cu(ClO4)·6H2O as catalyst and the corresponding O-protected-1-mercapto carbohydrate, furnished a mixture of three regioisomeric glycosylated products (modest yields) at C-11 (<5%), C-13 (10%) and C-15 (24%) positions, with conserved β-configuration. Figure 6 displays the structure of the thio-isoster of Fdx, obtained as a minor compound. Degradation studies in methanolic HCl revealed that, whereas Fdx underwent degradation (t1/2 = 62.7 min), S-Fdx was stable over a period of 540 min [37]. Additionally, although the substitution slightly reduced the antibacterial activity, S-Fdx retained potent efficacy against C. diff. (Minimum inhibitory concentrations (MIC) ranges of 0.12–4 µg/mL) and Clostridium perfringens (MIC ranges of 0.06‒0.5 µg/mL). Regioisomeric thioglycosides at C-13 and C-15 positions demonstrated to be inactive. Figure 6. Structure of thio-Fidaxomicin. Classical synthetic methodologies reported for the preparation of thioglycosides include reaction of thiols with per-O-acetylated carbohydrates, using Lewis acids as catalysts, reaction of thiolates with acetohalosugars, or 1-thioglycoderivatives with alkyl halides. The building blocks involved in such transformations are depicted in Scheme 5. Scheme 5. Classical procedures for preparing thioglycosides. In the search for eco-friendly methods to synthesize thioglycosides, Luo and coworkers developed [38] an innovative methodology based on the use of phosphotungstic acid (PTA) as a catalyst for the reaction of per-O-acetylated saccharides 34 (D-galactose, D-xylose, L-fucose) and thiols under microwave-assisted conditions (Scheme 6). Notably, PTA Figure 6. Structure of thio-Fidaxomicin. Classical synthetic methodologies reported for the preparation of thioglycosides include reaction of thiols with per-O-acetylated carbohydrates, using Lewis acids as catalysts, reaction of thiolates with acetohalosugars, or 1-thioglycoderivatives with alkyl halides. The building blocks involved in such transformations are depicted in Scheme 5. Molecules 2025, 30, x FOR PEER REVIEW 7 of 58 macrolactone Fidaxomicin (Fdx), approved for the Clostridioides difficile (C. diff.) infections; the authors replaced the O-glycosidic bond by the corresponding thioglycoside. Although the natural compound has shown promising activities against other pathogenic agents, its clinical use in other pathogens rather than C. diff. is hampered by its limited acid stability, making it difficult to treat, for example, stomach infections. Treatment of Fdx with Cu(ClO4)·6H2O as catalyst and the corresponding O-protected-1-mercapto carbohydrate, furnished a mixture of three regioisomeric glycosylated products (modest yields) at C-11 (<5%), C-13 (10%) and C-15 (24%) positions, with conserved β-configuration. Figure 6 displays the structure of the thio-isoster of Fdx, obtained as a minor compound. Degradation studies in methanolic HCl revealed that, whereas Fdx underwent degradation (t1/2 = 62.7 min), S-Fdx was stable over a period of 540 min [37]. Additionally, although the substitution slightly reduced the antibacterial activity, S-Fdx retained potent efficacy against C. diff. (Minimum inhibitory concentrations (MIC) ranges of 0.12–4 µg/mL) and Clostridium perfringens (MIC ranges of 0.06‒0.5 µg/mL). Regioisomeric thioglycosides at C-13 and C-15 positions demonstrated to be inactive. Figure 6. Structure of thio-Fidaxomicin. Classical synthetic methodologies reported for the preparation of thioglycosides include reaction of thiols with per-O-acetylated carbohydrates, using Lewis acids as catalysts, reaction of thiolates with acetohalosugars, or 1-thioglycoderivatives with alkyl halides. The building blocks involved in such transformations are depicted in Scheme 5. Scheme 5. Classical procedures for preparing thioglycosides. In the search for eco-friendly methods to synthesize thioglycosides, Luo and coworkers developed [38] an innovative methodology based on the use of phosphotungstic acid (PTA) as a catalyst for the reaction of per-O-acetylated saccharides 34 (D-galactose, D-xylose, L-fucose) and thiols under microwave-assisted conditions (Scheme 6). Notably, PTA Scheme 5. Classical procedures for preparing thioglycosides. In the search for eco-friendly methods to synthesize thioglycosides, Luo and coworkers developed [ 38 ] an innovative methodology based on the use of phosphotungstic acid (PTA) as a catalyst for the reaction of per-O-acetylated saccharides 34 (D-galactose, D-xylose, L-fucose) and thiols under microwave-assisted conditions (Scheme 6). Notably, PTA proved to be highly reusable, maintaining yields of 84–88% across multiple reactions with a recovery efficiency exceeding 80%. Furthermore, methanolic PTA was successfully utilized for the one-pot de-O-acetylation of acetoxy compounds to give fully unprotected thioglycosides 35. Molecules 2025, 30, x FOR PEER REVIEW 8 of 58 proved to be highly reusable, maintaining yields of 84‒88% across multiple reactions with a recovery efficiency exceeding 80%. Furthermore, methanolic PTA was successfully utilized for the one-pot de-O-acetylation of acetoxy compounds to give fully unprotected thioglycosides 35. Scheme 6. One-pot process for the thioglycoside formation and de-O-acetylation. Reagents and conditions: (a) PTA, HSR, DCM, MW, 30 min, 40 °C.; (b) PTA, MeOH, 90 °C, 4 h. In order to avoid handling alkyl thiols, which are frequently malodorous and toxic, Dong and coworkers developed [39] an efficient and environmentally friendly protocol that consisted of the reaction of sodium alkanethiolates with per-O-acetylated carbohydrates 34 in the presence of BF3·OEt2 under solventless conditions (Scheme 7). Interestingly, 1,2-trans-thioglycosides 35 could be isomerized into challenging 1,2-cis species 36 by treatment with TfOH in non-polar solvents and under mild conditions (Scheme 7). Scheme 7. Synthesis of thioalkylglycosides. Pd-catalyzed cross-coupling reactions have also been used for accessing thioglycosides. In this context, Domingues et al. employed [40] the third-generation Buchwald precatalyst (Pd-G3 Xantphos palladacycle) for functionalizing benzo-2,1,3-thiadiazole (BTD) at the C-5 position with 1-mercapto sugars 37 to give 39 (Scheme 8); the interest in such heterocyclic motif lies in the fact that it can be used as a fluorescent marker. The scope of the reaction was analyzed on pyranoses (D-Glc, D-Man, D-Gal, D-Xyl, L-Ara), furanoses (D-Rib) and disaccharides (maltose, lactose), and was found to proceed under mild conditions and to be compatible with an ample variety of functional groups. The yields were from good to almost quantitative, except for per-O-acetylated D-mannopyranose and D-ribofuranose, whose thioglycosides were obtained in modest yields; retention of the β-configuration was observed. The lowest yields could be significantly increased by changing the catalyst to Pd G3-MorDalphos. Products were deprotected using Zemplentype conditions. Scheme 8. Pd-catalyzed C–S cross-coupling reaction between thiosugars and BTD. Reagents and conditions: (a) Pd catalyst 4-5 mol%, Et3N, 1,4-dioxane, 90 °C; (b) K2CO3 (cat.), MeOH. Scheme 6. One-pot process for the thioglycoside formation and de-O-acetylation. Reagents and conditions: (a) PTA, HSR, DCM, MW, 30 min, 40 ◦C.; (b) PTA, MeOH, 90 ◦C, 4 h. In order to avoid handling alkyl thiols, which are frequently malodorous and toxic, Dong and coworkers developed [ 39 ] an efficient and environmentally friendly protocol that consisted of the reaction of sodium alkanethiolates with per-O-acetylated carbohydrates 34 in the presence of BF 3· OEt 2 under solventless conditions (Scheme 7). Interestingly, Molecules 2025,30, 2053 8 of 54 1,2-trans-thioglycosides 35 could be isomerized into challenging 1,2-cis species 36 by treatment with TfOH in non-polar solvents and under mild conditions (Scheme 7). Molecules 2025, 30, x FOR PEER REVIEW 8 of 58 proved to be highly reusable, maintaining yields of 84‒88% across multiple reactions with a recovery efficiency exceeding 80%. Furthermore, methanolic PTA was successfully utilized for the one-pot de-O-acetylation of acetoxy compounds to give fully unprotected thioglycosides 35. Scheme 6. One-pot process for the thioglycoside formation and de-O-acetylation. Reagents and conditions: (a) PTA, HSR, DCM, MW, 30 min, 40 °C.; (b) PTA, MeOH, 90 °C, 4 h. In order to avoid handling alkyl thiols, which are frequently malodorous and toxic, Dong and coworkers developed [39] an efficient and environmentally friendly protocol that consisted of the reaction of sodium alkanethiolates with per-O-acetylated carbohydrates 34 in the presence of BF3·OEt2 under solventless conditions (Scheme 7). Interestingly, 1,2-trans-thioglycosides 35 could be isomerized into challenging 1,2-cis species 36 by treatment with TfOH in non-polar solvents and under mild conditions (Scheme 7). Scheme 7. Synthesis of thioalkylglycosides. Pd-catalyzed cross-coupling reactions have also been used for accessing thioglycosides. In this context, Domingues et al. employed [40] the third-generation Buchwald precatalyst (Pd-G3 Xantphos palladacycle) for functionalizing benzo-2,1,3-thiadiazole (BTD) at the C-5 position with 1-mercapto sugars 37 to give 39 (Scheme 8); the interest in such heterocyclic motif lies in the fact that it can be used as a fluorescent marker. The scope of the reaction was analyzed on pyranoses (D-Glc, D-Man, D-Gal, D-Xyl, L-Ara), furanoses (D-Rib) and disaccharides (maltose, lactose), and was found to proceed under mild conditions and to be compatible with an ample variety of functional groups. The yields were from good to almost quantitative, except for per-O-acetylated D-mannopyranose and D-ribofuranose, whose thioglycosides were obtained in modest yields; retention of the β-configuration was observed. The lowest yields could be significantly increased by changing the catalyst to Pd G3-MorDalphos. Products were deprotected using Zemplentype conditions. Scheme 8. Pd-catalyzed C–S cross-coupling reaction between thiosugars and BTD. Reagents and conditions: (a) Pd catalyst 4-5 mol%, Et3N, 1,4-dioxane, 90 °C; (b) K2CO3 (cat.), MeOH. Scheme 7. Synthesis of thioalkylglycosides. Pd-catalyzed cross-coupling reactions have also been used for accessing thioglycosides. In this context, Domingues et al. employed [ 40 ] the third-generation Buchwald precatalyst (Pd-G3 Xantphos palladacycle) for functionalizing benzo-2,1,3-thiadiazole (BTD) at the C-5 position with 1-mercapto sugars 37 to give 39 (Scheme 8); the interest in such heterocyclic motif lies in the fact that it can be used as a fluorescent marker. The scope of the reaction was analyzed on pyranoses (D-Glc, D-Man, D-Gal, D-Xyl, L-Ara), furanoses (D-Rib) and disaccharides (maltose, lactose), and was found to proceed under mild conditions and to be compatible with an ample variety of functional groups. The yields were from good to almost quantitative, except for per-O-acetylated D-mannopyranose and D-ribofuranose, whose thioglycosides were obtained in modest yields; retention of the β -configuration was observed. The lowest yields could be significantly increased by changing the catalyst to Pd G3-MorDalphos. Products were deprotected using Zemplen-type conditions. Molecules 2025, 30, x FOR PEER REVIEW 8 of 58 proved to be highly reusable, maintaining yields of 84‒88% across multiple reactions with a recovery efficiency exceeding 80%. Furthermore, methanolic PTA was successfully utilized for the one-pot de-O-acetylation of acetoxy compounds to give fully unprotected thioglycosides 35. Scheme 6. One-pot process for the thioglycoside formation and de-O-acetylation. Reagents and conditions: (a) PTA, HSR, DCM, MW, 30 min, 40 °C.; (b) PTA, MeOH, 90 °C, 4 h. In order to avoid handling alkyl thiols, which are frequently malodorous and toxic, Dong and coworkers developed [39] an efficient and environmentally friendly protocol that consisted of the reaction of sodium alkanethiolates with per-O-acetylated carbohydrates 34 in the presence of BF3·OEt2 under solventless conditions (Scheme 7). Interestingly, 1,2-trans-thioglycosides 35 could be isomerized into challenging 1,2-cis species 36 by treatment with TfOH in non-polar solvents and under mild conditions (Scheme 7). Scheme 7. Synthesis of thioalkylglycosides. Pd-catalyzed cross-coupling reactions have also been used for accessing thioglycosides. In this context, Domingues et al. employed [40] the third-generation Buchwald precatalyst (Pd-G3 Xantphos palladacycle) for functionalizing benzo-2,1,3-thiadiazole (BTD) at the C-5 position with 1-mercapto sugars 37 to give 39 (Scheme 8); the interest in such heterocyclic motif lies in the fact that it can be used as a fluorescent marker. The scope of the reaction was analyzed on pyranoses (D-Glc, D-Man, D-Gal, D-Xyl, L-Ara), furanoses (D-Rib) and disaccharides (maltose, lactose), and was found to proceed under mild conditions and to be compatible with an ample variety of functional groups. The yields were from good to almost quantitative, except for per-O-acetylated D-mannopyranose and D-ribofuranose, whose thioglycosides were obtained in modest yields; retention of the β-configuration was observed. The lowest yields could be significantly increased by changing the catalyst to Pd G3-MorDalphos. Products were deprotected using Zemplentype conditions. Scheme 8. Pd-catalyzed C–S cross-coupling reaction between thiosugars and BTD. Reagents and conditions: (a) Pd catalyst 4-5 mol%, Et3N, 1,4-dioxane, 90 °C; (b) K2CO3 (cat.), MeOH. Scheme 8. Pd-catalyzed C–S cross-coupling reaction between thiosugars and BTD. Reagents and conditions: (a) Pd catalyst 4-5 mol%, Et3N, 1,4-dioxane, 90 ◦C; (b) K2CO3(cat.), MeOH. Pd-catalyzed Migita cross-coupling reaction between a racemic mixture of o-iodo S-trifluoromethyl-S-arylsulfoximines 41 and a great variety of 1-mercapto sugars (mono-, diand trisaccharides) has been used in the preparation of thioglycosides 42/43 [ 41 ]. For that purpose, PdG3-XantPhos was used as the catalyst, and Et 3 N as base (Scheme 9). A single β -anomer was obtained, in a 1:1 diastereomeric mixture, that was efficiently separated by either crystallization or HPLC. Molecules 2025, 30, x FOR PEER REVIEW 9 of 58 Pd-catalyzed Migita cross-coupling reaction between a racemic mixture of o-iodo Strifluoromethyl-S-arylsulfoximines 41 and a great variety of 1-mercapto sugars (mono-, diand trisaccharides) has been used in the preparation of thioglycosides 42/43 [41]. For that purpose, PdG3-XantPhos was used as the catalyst, and Et3N as base (Scheme 9). A single β-anomer was obtained, in a 1:1 diastereomeric mixture, that was efficiently separated by either crystallization or HPLC. Scheme 9. Migita cross-coupling reaction for the synthesis of thioglycosides. Reagents and conditions: (a) PdG3-XantPhos, Et3N (1.5 equiv), dioxane, 15‒30 min. O-Protected 1-thio-monoand disaccharides 37 were efficiently coupled [42] with aryl-naphthoquinones 44 (Scheme 10) in the presence of 45, a chiral squaramide as the organocatalyst. The corresponding axially chiral thioglycosides 46 were obtained, in general, with high diastereoselectivity (14:1 to >19:1 dr). It was claimed that the hydrogen bonding established between the bifunctional organocatalyst and the quinone had a pivotal role in the activation of the substrate and the stereocontrol, locking a major conformation of the biphenyl residue at the transition state with the lowest sterical hindrance. Scheme 10. Stereoselective synthesis of naphthoquinone thioglycosides using a squaramide-based organocatalyst. Isothiouronium salts are interesting synthetic intermediates, and can be obtained from fully O-acetylated carbohydrates 34 by treatment with BF3·OEt2 to give tentatively a 1,2-acyloxonium ion [43]. Reaction of the latter with thiourea as a nucleophile, affords the corresponding isothiouronium derivative 47, exclusively with the 1,2-trans-arrangement (Scheme 11). Hydrolysis of 47 under weakly basic conditions (Et3N) gives access to a transient thiolate (48), which exerts a 1,6 nucleophilic addition on p-quinone methide, with the subsequent formation of diarylmethyl thioglycosides 49. Scheme 9. Migita cross-coupling reaction for the synthesis of thioglycosides. Reagents and conditions: (a) PdG3-XantPhos, Et3N (1.5 equiv), dioxane, 15–30 min. O-Protected 1-thio-monoand disaccharides 37 were efficiently coupled [ 42 ] with aryl-naphthoquinones 44 (Scheme 10) in the presence of 45, a chiral squaramide as the Molecules 2025,30, 2053 9 of 54 organocatalyst. The corresponding axially chiral thioglycosides 46 were obtained, in general, with high diastereoselectivity (14:1 to >19:1 dr). It was claimed that the hydrogen bonding established between the bifunctional organocatalyst and the quinone had a pivotal role in the activation of the substrate and the stereocontrol, locking a major conformation of the biphenyl residue at the transition state with the lowest sterical hindrance. Molecules 2025, 30, x FOR PEER REVIEW 9 of 58 Pd-catalyzed Migita cross-coupling reaction between a racemic mixture of o-iodo Strifluoromethyl-S-arylsulfoximines 41 and a great variety of 1-mercapto sugars (mono-, diand trisaccharides) has been used in the preparation of thioglycosides 42/43 [41]. For that purpose, PdG3-XantPhos was used as the catalyst, and Et3N as base (Scheme 9). A single β-anomer was obtained, in a 1:1 diastereomeric mixture, that was efficiently separated by either crystallization or HPLC. Scheme 9. Migita cross-coupling reaction for the synthesis of thioglycosides. Reagents and conditions: (a) PdG3-XantPhos, Et3N (1.5 equiv), dioxane, 15‒30 min. O-Protected 1-thio-monoand disaccharides 37 were efficiently coupled [42] with aryl-naphthoquinones 44 (Scheme 10) in the presence of 45, a chiral squaramide as the organocatalyst. The corresponding axially chiral thioglycosides 46 were obtained, in general, with high diastereoselectivity (14:1 to >19:1 dr). It was claimed that the hydrogen bonding established between the bifunctional organocatalyst and the quinone had a pivotal role in the activation of the substrate and the stereocontrol, locking a major conformation of the biphenyl residue at the transition state with the lowest sterical hindrance. Scheme 10. Stereoselective synthesis of naphthoquinone thioglycosides using a squaramide-based organocatalyst. Isothiouronium salts are interesting synthetic intermediates, and can be obtained from fully O-acetylated carbohydrates 34 by treatment with BF3·OEt2 to give tentatively a 1,2-acyloxonium ion [43]. Reaction of the latter with thiourea as a nucleophile, affords the corresponding isothiouronium derivative 47, exclusively with the 1,2-trans-arrangement (Scheme 11). Hydrolysis of 47 under weakly basic conditions (Et3N) gives access to a transient thiolate (48), which exerts a 1,6 nucleophilic addition on p-quinone methide, with the subsequent formation of diarylmethyl thioglycosides 49. Scheme 10. Stereoselective synthesis of naphthoquinone thioglycosides using a squaramide-based organocatalyst. Isothiouronium salts are interesting synthetic intermediates, and can be obtained from fully O-acetylated carbohydrates 34 by treatment with BF 3· OEt 2 to give tentatively a 1,2-acyloxonium ion [43]. Reaction of the latter with thiourea as a nucleophile, affords the corresponding isothiouronium derivative 47, exclusively with the 1,2-trans-arrangement (Scheme 11). Hydrolysis of 47 under weakly basic conditions (Et 3 N) gives access to a transient thiolate (48), which exerts a 1,6 nucleophilic addition on p-quinone methide, with the subsequent formation of diarylmethyl thioglycosides 49. Molecules 2025, 30, x FOR PEER REVIEW 10 of 58 Scheme 11. Synthesis of diarylmethyl thioglycosides. Aryldiazonium salts are known for their inherent electrophilicity, and have been used in the formation of C–S bonds. Building on this property, Venkatesh et al. developed [44] a reaction between thiosugars 40 and activated aryldiazonium salts 50 (Scheme 12) to efficiently form C‒S bonds (S-arylation, compounds 51). The optimized conditions involved the use of CuCl as the catalyst, DBU as the base, low temperatures (0‒5 °C) and short reaction times (<5 min). Under these conditions, diazosulfide (R-S-N=N-Ar) is not observed, and only small amounts of the competing dimer (R-S-S-R) was obtained. The reaction was compatible with an ample number of protecting groups (NHAc, Ac, Bn, Bz), and even with unprotected carbohydrates; however, in this case, the ratio of the undesired dimeric disulfides increased [44]. It was postulated that the key intermediate is a free radical, obtained upon reaction of the aryldiazonium salt with the Cu(I) catalyst. This mechanism was demonstrated by the addition of a free radical scavenger (TEMPO), furnishing only traces of 51 [44]. Scheme 12. Synthesis S-aryl thioglycosides. Reagents and conditions: (a) CuCl (5%), DBU (1 eq), MeCN, 0‒5 °C. This approach enabled the successful synthesis of thio-analogues of bioactive compounds, including the antidiabetic agent dapagliflozin (52) [45,46], and the tyrosinase inhibitor arbutin (53) (Figure 7). Figure 7. Thio-analogues of dapagliflozin and arbutin. A stereospecific metal-free synthesis of aryl thioglycosides 51 was achieved by using a boron catalyst for promoting a reductive deoxygenation coupling reaction between Oprotected α-acetobromohexoses 54 (also diand trisaccharides) and sulfonyl chlorides 55 (Scheme 13) [47]; B2pin2 (Bis(pinacolato)diboron) and PPh3 were used as additives. This afScheme 11. Synthesis of diarylmethyl thioglycosides. Aryldiazonium salts are known for their inherent electrophilicity, and have been used in the formation of C–S bonds. Building on this property, Venkatesh et al. developed [ 44 ] a reaction between thiosugars 40 and activated aryldiazonium salts 50 (Scheme 12) to efficiently form C–S bonds (S-arylation, compounds 51). The optimized conditions involved the use of CuCl as the catalyst, DBU as the base, low temperatures (0–5 ◦ C) and short reaction times (<5 min). Under these conditions, diazosulfide (R-S-N=N-Ar) is not observed, and only small amounts of the competing dimer (R-S-S-R) was obtained. The reaction was compatible with an ample number of protecting groups (NHAc, Ac, Bn, Bz), and even with unprotected carbohydrates; however, in this case, the ratio of the undesired dimeric disulfides increased [ 44 ]. It was postulated that the key intermediate is a free radical, Molecules 2025,30, 2053 16 of 54 Molecules 2025, 30, x FOR PEER REVIEW 16 of 58 Scheme 18. Synthesis of pseudo-disaccharides from 1-thio-β-D-mannosides and 1-thio-β-L-rhamnosides. Photoinitiated thiol-ene coupling reactions were used by Borbás and co-workers for preparing S-linked pseudo-disaccharides [61]. These glycomimetics were obtained by UV-induction of hydrothiolation reactions between unsaturated sugars bearing an exocyclic double bond at C1, C2, C3, C4, C5 and C6 positions and a thiol-containing sugar (Scheme 19). 2,2-Dimethoxy-2-phenylacetophenone (DPAP) was used as the photoinitiator. Reaction proceeds in a two-step pathway: reversible addition of the thiyl free radical, and the irreversible donation of hydrogen atom from a thiol; although the stereoselectivity strongly depends on the carbohydrate involved, a preferential axial H-transfer is frequently observed, with the thiol substituent occupying the equatorial position [61]. Scheme 19. Reactions of enopyranoses bearing an exocyclic double bond. Using this methodology, the sialyl thioglycoside 86 was obtained in good yield (Scheme 20). Scheme 19. Reactions of enopyranoses bearing an exocyclic double bond. Using this methodology, the sialyl thioglycoside 86 was obtained in good yield (Scheme 20). Molecules 2025, 30, x FOR PEER REVIEW 17 of 58 O OH HO HO OH S O OH OH OMe HO O OH HO HO OH S O OH OH OMe HO O OR N NHTrt tBuOCl (1.1 eq.) THF, 20 °C O OR N NHTrt RSH (80 eq.) 5 °C O OR Cl87 88 89 SR 90 91 O OH HO HO OH F HS O OH OH OMe HO + AcS O OH OH OMe HO 92 93 94 Scheme 20. Synthesis of thiosugars from sugar-derived trityl hydrazones. A straightforward alternative for preparing O-unprotected S-linked pseudo-disaccharides consists of the preparation of sugar-derived trityl hydrazones 87, which upon treatment with tBuOCl generate a chloro-azo intermediate on the sugar moiety [62]. Thermolysis of such intermediate in the presence of an excess of simple thiols generates thioethers 89 in up to almost quantitative yield (Scheme 20). This methodology was applied to the preparation of pseudo-disaccharides 90 and 91, which were obtained by treatment of trityl hydrazone 87 with AcSH to give 94, followed by hydrolysis of the acetyl moiety, and coupling of the corresponding 3-thiols 93 with glucopyranosyl fluoride 92 (Scheme 20) [62]. Automated syntheses have also been applied to the selective incorporation of S-glycosides into oligomannopyranosides [63] using an inverse glycosylation protocol instead of the conventional methodology. The synthesis of trisaccharide 97 was accomplished with good yield (73%) employing reactive glycosyl acceptor 95, glycosyl donor 96, and TMSOTf as the promoter (Scheme 21). The process comprised three sequential cycles of glycosylation coupling, deprotection, and purification. The automated protocol was executed on a platform equipped with a robotic arm and dual syringe pumps, enabling precise delivery of reagents to an array of double-jacketed reaction vessels. The reaction setup was maintained under an inert atmosphere, ensuring controlled and reproducible conditions for each step of the synthesis [63]. Scheme 20. Synthesis of thiosugars from sugar-derived trityl hydrazones. A straightforward alternative for preparing O-unprotected S-linked pseudo-disaccharides consists of the preparation of sugar-derived trityl hydrazones 87, which upon treatment with tBuOCl generate a chloro-azo intermediate on the sugar moiety [ 62 ]. Thermolysis of such intermediate in the presence of an excess of simple thiols generates thioethers 89 in up to almost quantitative yield (Scheme 20). This methodology was applied to the preparation of pseudo-disaccharides 90 and 91, which were obtained by treatment of trityl hydrazone 87 with AcSH to give 94, followed by hydrolysis of the acetyl moiety, and coupling of the corresponding 3-thiols 93 with glucopyranosyl fluoride 92 (Scheme 20) [62]. Molecules 2025,30, 2053 17 of 54 Automated syntheses have also been applied to the selective incorporation of Sglycosides into oligomannopyranosides [ 63 ] using an inverse glycosylation protocol instead of the conventional methodology. The synthesis of trisaccharide 97 was accomplished with good yield (73%) employing reactive glycosyl acceptor 95, glycosyl donor 96, and TMSOTf as the promoter (Scheme 21). The process comprised three sequential cycles of glycosylation coupling, deprotection, and purification. The automated protocol was executed on a platform equipped with a robotic arm and dual syringe pumps, enabling precise delivery of reagents to an array of double-jacketed reaction vessels. The reaction setup was maintained under an inert atmosphere, ensuring controlled and reproducible conditions for each step of the synthesis [63]. Molecules 2025, 30, x FOR PEER REVIEW 17 of 58 O OH HO HO OH S O OH OH OMe HO O OH HO HO OH S O OH OH OMe HO O OR N NHTrt tBuOCl (1.1 eq.) THF, 20 °C O OR N NHTrt RSH (80 eq.) 5 °C O OR Cl87 88 89 SR 90 91 O OH HO HO OH F HS O OH OH OMe HO + AcS O OH OH OMe HO 92 93 94 Scheme 20. Synthesis of thiosugars from sugar-derived trityl hydrazones. A straightforward alternative for preparing O-unprotected S-linked pseudo-disaccharides consists of the preparation of sugar-derived trityl hydrazones 87, which upon treatment with tBuOCl generate a chloro-azo intermediate on the sugar moiety [62]. Thermolysis of such intermediate in the presence of an excess of simple thiols generates thioethers 89 in up to almost quantitative yield (Scheme 20). This methodology was applied to the preparation of pseudo-disaccharides 90 and 91, which were obtained by treatment of trityl hydrazone 87 with AcSH to give 94, followed by hydrolysis of the acetyl moiety, and coupling of the corresponding 3-thiols 93 with glucopyranosyl fluoride 92 (Scheme 20) [62]. Automated syntheses have also been applied to the selective incorporation of S-glycosides into oligomannopyranosides [63] using an inverse glycosylation protocol instead of the conventional methodology. The synthesis of trisaccharide 97 was accomplished with good yield (73%) employing reactive glycosyl acceptor 95, glycosyl donor 96, and TMSOTf as the promoter (Scheme 21). The process comprised three sequential cycles of glycosylation coupling, deprotection, and purification. The automated protocol was executed on a platform equipped with a robotic arm and dual syringe pumps, enabling precise delivery of reagents to an array of double-jacketed reaction vessels. The reaction setup was maintained under an inert atmosphere, ensuring controlled and reproducible conditions for each step of the synthesis [63]. Scheme 21. Automated approach for the synthesis of oligomannopyranosides. 2.3. 3-Thiosugars Incorporation of a sulfur atom at C-3 position of a sugar residue has been used for accessing valuable synthetic intermediates, as well as for preparing derivatives with potential biological activities [ 64 ]. Despite that, this kind of sulfur-containing carbohydrates is significantly less studied compared to other positions on the sugar, like the endocyclic oxygen, or the glycosidic position. A frequent approach for accessing 3-thiosugars is the reaction of glycals with different thiols and catalysts, as displayed in this section. Mukherjee et al. reported [ 65 ] the biomimetic synthesis of a family of 3-thiosugars (100, Scheme 22) via reaction of 2-ketophenyl-glycals 98,99 (D-glucal, D-galactal, L-rhamnal) with different thiols. The regioand stereoselective displacement of the acetoxy group at the C-3 position of the glycal was achieved using aromatic and cyclic aliphatic thiols under mild basic conditions (Et 3 N), furnishing excellent axial selectivity. The presence of a carbonyl group at C-2 was found to be crucial [ 65 ]. It was hypothesized that the thiol attacks the carbonyl group at C-2, and then it undergoes a 1,3-migration through the opposite face of the acetoxy group at C-3. This process was inspired by the thiolation of glucosamine by cytosolic esterases. Molecules 2025, 30, x FOR PEER REVIEW 18 of 58 Scheme 21. Automated approach for the synthesis of oligomannopyranosides. 2.3. 3-Thiosugars Incorporation of a sulfur atom at C-3 position of a sugar residue has been used for accessing valuable synthetic intermediates, as well as for preparing derivatives with potential biological activities [64]. Despite that, this kind of sulfur-containing carbohydrates is significantly less studied compared to other positions on the sugar, like the endocyclic oxygen, or the glycosidic position. A frequent approach for accessing 3-thiosugars is the reaction of glycals with different thiols and catalysts, as displayed in this section. Mukherjee et al. reported [65] the biomimetic synthesis of a family of 3-thiosugars (100, Scheme 22) via reaction of 2-ketophenyl-glycals 98, 99 (D-glucal, D-galactal, L-rhamnal) with different thiols. The regioand stereoselective displacement of the acetoxy group at the C-3 position of the glycal was achieved using aromatic and cyclic aliphatic thiols under mild basic conditions (Et3N), furnishing excellent axial selectivity. The presence of a carbonyl group at C-2 was found to be crucial [65]. It was hypothesized that the thiol attacks the carbonyl group at C-2, and then it undergoes a 1,3-migration through the opposite face of the acetoxy group at C-3. This process was inspired by the thiolation of glucosamine by cytosolic esterases. Scheme 22. Synthesis of a library of 3-aryl/alkyl thiosugars prepared from 2-ketoglycals. Reagents and conditions: (a) Et3N (1 equiv.), MeCN, r.t. Liu and coworkers reported [66] the stereoand regioselective synthesis of thiosugars by reaction of 3,4-O-carbonate glycals 101 with different thiols; competitive experiments revealed that the thiol group reacted with total chemoselectivity in the presence of other nucleophilic moieties, like alcohols, phenols, amides, or amines. A regiodivergent approach was developed, as depending on the catalyst employed, either 3-thiosugars (with Co(BF4)2, axial position, compound 102) or 1-thiosugars (with Pd2(dba)3, equatorial position, compound 103) were obtained, with general good yields (Scheme 23). Based on computational calculations, it was hypothesized that under Pd catalysis, the thiol group established hydrogen bonding on the top face with the oxygen atom at C-4 position. Nevertheless, coordination with Co took place through the bottom face. Scheme 23. Synthesis of 1and 3-thiosugars using Co and Pd-based catalysts. Reagents and conditions: (a) RSH, Co(BF4)2 catalyst, CH2Cl2, 35 °C; (b) RSH, Pd2(dba)3 catalyst, 100 °C. Scheme 22. Synthesis of a library of 3-aryl/alkyl thiosugars prepared from 2-ketoglycals. Reagents and conditions: (a) Et3N (1 equiv.), MeCN, r.t. Molecules 2025,30, 2053 18 of 54 Liu and coworkers reported [ 66 ] the stereoand regioselective synthesis of thiosugars by reaction of 3,4-O-carbonate glycals 101 with different thiols; competitive experiments revealed that the thiol group reacted with total chemoselectivity in the presence of other nucleophilic moieties, like alcohols, phenols, amides, or amines. A regiodivergent approach was developed, as depending on the catalyst employed, either 3-thiosugars (with Co(BF 4 ) 2 , axial position, compound 102) or 1-thiosugars (with Pd 2 (dba) 3 , equatorial position, compound 103) were obtained, with general good yields (Scheme 23). Based on computational calculations, it was hypothesized that under Pd catalysis, the thiol group established hydrogen bonding on the top face with the oxygen atom at C-4 position. Nevertheless, coordination with Co took place through the bottom face. Molecules 2025, 30, x FOR PEER REVIEW 18 of 58 Scheme 21. Automated approach for the synthesis of oligomannopyranosides. 2.3. 3-Thiosugars Incorporation of a sulfur atom at C-3 position of a sugar residue has been used for accessing valuable synthetic intermediates, as well as for preparing derivatives with potential biological activities [64]. Despite that, this kind of sulfur-containing carbohydrates is significantly less studied compared to other positions on the sugar, like the endocyclic oxygen, or the glycosidic position. A frequent approach for accessing 3-thiosugars is the reaction of glycals with different thiols and catalysts, as displayed in this section. Mukherjee et al. reported [65] the biomimetic synthesis of a family of 3-thiosugars (100, Scheme 22) via reaction of 2-ketophenyl-glycals 98, 99 (D-glucal, D-galactal, L-rhamnal) with different thiols. The regioand stereoselective displacement of the acetoxy group at the C-3 position of the glycal was achieved using aromatic and cyclic aliphatic thiols under mild basic conditions (Et3N), furnishing excellent axial selectivity. The presence of a carbonyl group at C-2 was found to be crucial [65]. It was hypothesized that the thiol attacks the carbonyl group at C-2, and then it undergoes a 1,3-migration through the opposite face of the acetoxy group at C-3. This process was inspired by the thiolation of glucosamine by cytosolic esterases. Scheme 22. Synthesis of a library of 3-aryl/alkyl thiosugars prepared from 2-ketoglycals. Reagents and conditions: (a) Et3N (1 equiv.), MeCN, r.t. Liu and coworkers reported [66] the stereoand regioselective synthesis of thiosugars by reaction of 3,4-O-carbonate glycals 101 with different thiols; competitive experiments revealed that the thiol group reacted with total chemoselectivity in the presence of other nucleophilic moieties, like alcohols, phenols, amides, or amines. A regiodivergent approach was developed, as depending on the catalyst employed, either 3-thiosugars (with Co(BF4)2, axial position, compound 102) or 1-thiosugars (with Pd2(dba)3, equatorial position, compound 103) were obtained, with general good yields (Scheme 23). Based on computational calculations, it was hypothesized that under Pd catalysis, the thiol group established hydrogen bonding on the top face with the oxygen atom at C-4 position. Nevertheless, coordination with Co took place through the bottom face. Scheme 23. Synthesis of 1and 3-thiosugars using Co and Pd-based catalysts. Reagents and conditions: (a) RSH, Co(BF4)2 catalyst, CH2Cl2, 35 °C; (b) RSH, Pd2(dba)3 catalyst, 100 °C. Scheme 23. Synthesis of 1and 3-thiosugars using Co and Pd-based catalysts. Reagents and conditions: (a) RSH, Co(BF4)2catalyst, CH2Cl2, 35 ◦C; (b) RSH, Pd2(dba)3catalyst, 100 ◦C. Chen and co-workers noticed [ 67 ] that per-O-acetylated unnatural monosaccharides and the cysteine residues on proteins undergo an atypical glycosylation process, yielding 3-thiolated sugars in their hemiacetal form. In their study, the authors elucidated an elimination-addition mechanism, which involves a base-promoted β -elimination step followed by a Michael addition of the cysteine residue to the α , β -unsaturated aldehyde. (Scheme 24). This process, called S-glycosylation, might compromise the specificity of the metabolic glycan labelling (MGL) used, for example, in glycan tagging with fluorophores. Molecules 2025, 30, x FOR PEER REVIEW 19 of 58 Chen and co-workers noticed [67] that per-O-acetylated unnatural monosaccharides and the cysteine residues on proteins undergo an atypical glycosylation process, yielding 3-thiolated sugars in their hemiacetal form. In their study, the authors elucidated an elimination-addition mechanism, which involves a base-promoted β-elimination step followed by a Michael addition of the cysteine residue to the α,β-unsaturated aldehyde. (Scheme 24). This process, called S-glycosylation, might compromise the specificity of the metabolic glycan labelling (MGL) used, for example, in glycan tagging with fluorophores. Scheme 24. Proposed two-step elimination–addition mechanism for S-glyco-modification. 2.4. Other Thiosugars 1,6-Anhydro-1-thio-β-D-hexopyranose derivatives are relevant molecules in Medicinal and Synthetic Chemistry, functioning as precursors of glycomimetics. Misra’s group has developed [68] a fast, effective, and scalable method for their synthesis by treatment of protected 6-O-tosylated glycopyranosyl bromide derivatives 104 with Na2S·9H2O (2 equiv.) and CS2 (2 equiv.) at rt (Scheme 25). The reaction was completed in just 5 min, yielding the corresponding thiolevoglucosan derivatives 105 with yields ranging from 82% to 92%. Scheme 25. Synthesis of 6-anhydro-1-thio-β-D-hexopyranose derivatives. Reagents and conditions: (a) Na2S·9H2O (2 equiv), CS2 (2 equiv), DMF, r.t. Using the same combination of reactants, the authors extended [69] the methodology to synthesize unsymmetrical glycosyl disulfides directly from glycosyl bromides by incorporating symmetrical disulfides. Under optimized conditions, a series of anomeric glycosyl bromides 54 were treated with symmetrical alkyl, aryl, and glycosyl disulfides, affording unsymmetrical β-glycosyl disulfides 106 in yields ranging from 72% to 90% (Scheme 26). Scheme 26. Synthesis of unsymmetrical glycosyl disulfides. Reagents and conditions: (a) CS2 (2 equiv.), Na2S·9H2O (2 equiv.), RSSR, DMF, 0 °C, rt, 5‒20 min. Scheme 24. Proposed two-step elimination–addition mechanism for S-glyco-modification. 2.4. Other Thiosugars 1,6-Anhydro-1-thioβ -D-hexopyranose derivatives are relevant molecules in Medicinal and Synthetic Chemistry, functioning as precursors of glycomimetics. Misra’s group has developed [ 68 ] a fast, effective, and scalable method for their synthesis by treatment of protected 6-O-tosylated glycopyranosyl bromide derivatives 104 with Na 2 S · 9H 2 O (2 equiv.) and CS 2 (2 equiv.) at rt (Scheme 25). The reaction was completed in just 5 min, yielding the corresponding thiolevoglucosan derivatives 105 with yields ranging from 82% to 92%. Molecules 2025,30, 2053 19 of 54 Molecules 2025, 30, x FOR PEER REVIEW 19 of 58 Chen and co-workers noticed [67] that per-O-acetylated unnatural monosaccharides and the cysteine residues on proteins undergo an atypical glycosylation process, yielding 3-thiolated sugars in their hemiacetal form. In their study, the authors elucidated an elimination-addition mechanism, which involves a base-promoted β-elimination step followed by a Michael addition of the cysteine residue to the α,β-unsaturated aldehyde. (Scheme 24). This process, called S-glycosylation, might compromise the specificity of the metabolic glycan labelling (MGL) used, for example, in glycan tagging with fluorophores. Scheme 24. Proposed two-step elimination–addition mechanism for S-glyco-modification. 2.4. Other Thiosugars 1,6-Anhydro-1-thio-β-D-hexopyranose derivatives are relevant molecules in Medicinal and Synthetic Chemistry, functioning as precursors of glycomimetics. Misra’s group has developed [68] a fast, effective, and scalable method for their synthesis by treatment of protected 6-O-tosylated glycopyranosyl bromide derivatives 104 with Na2S·9H2O (2 equiv.) and CS2 (2 equiv.) at rt (Scheme 25). The reaction was completed in just 5 min, yielding the corresponding thiolevoglucosan derivatives 105 with yields ranging from 82% to 92%. Scheme 25. Synthesis of 6-anhydro-1-thio-β-D-hexopyranose derivatives. Reagents and conditions: (a) Na2S·9H2O (2 equiv), CS2 (2 equiv), DMF, r.t. Using the same combination of reactants, the authors extended [69] the methodology to synthesize unsymmetrical glycosyl disulfides directly from glycosyl bromides by incorporating symmetrical disulfides. Under optimized conditions, a series of anomeric glycosyl bromides 54 were treated with symmetrical alkyl, aryl, and glycosyl disulfides, affording unsymmetrical β-glycosyl disulfides 106 in yields ranging from 72% to 90% (Scheme 26). Scheme 26. Synthesis of unsymmetrical glycosyl disulfides. Reagents and conditions: (a) CS2 (2 equiv.), Na2S·9H2O (2 equiv.), RSSR, DMF, 0 °C, rt, 5‒20 min. Scheme 25. Synthesis of 6-anhydro-1-thioβ -D-hexopyranose derivatives. Reagents and conditions: (a) Na2S·9H2O (2 equiv), CS2(2 equiv), DMF, r.t. Using the same combination of reactants, the authors extended [ 69 ] the methodology to synthesize unsymmetrical glycosyl disulfides directly from glycosyl bromides by incorporating symmetrical disulfides. Under optimized conditions, a series of anomeric glycosyl bromides 54 were treated with symmetrical alkyl, aryl, and glycosyl disulfides, affording unsymmetrical β-glycosyl disulfides 106 in yields ranging from 72% to 90% (Scheme 26). Molecules 2025, 30, x FOR PEER REVIEW 19 of 58 Chen and co-workers noticed [67] that per-O-acetylated unnatural monosaccharides and the cysteine residues on proteins undergo an atypical glycosylation process, yielding 3-thiolated sugars in their hemiacetal form. In their study, the authors elucidated an elimination-addition mechanism, which involves a base-promoted β-elimination step followed by a Michael addition of the cysteine residue to the α,β-unsaturated aldehyde. (Scheme 24). This process, called S-glycosylation, might compromise the specificity of the metabolic glycan labelling (MGL) used, for example, in glycan tagging with fluorophores. Scheme 24. Proposed two-step elimination–addition mechanism for S-glyco-modification. 2.4. Other Thiosugars 1,6-Anhydro-1-thio-β-D-hexopyranose derivatives are relevant molecules in Medicinal and Synthetic Chemistry, functioning as precursors of glycomimetics. Misra’s group has developed [68] a fast, effective, and scalable method for their synthesis by treatment of protected 6-O-tosylated glycopyranosyl bromide derivatives 104 with Na2S·9H2O (2 equiv.) and CS2 (2 equiv.) at rt (Scheme 25). The reaction was completed in just 5 min, yielding the corresponding thiolevoglucosan derivatives 105 with yields ranging from 82% to 92%. Scheme 25. Synthesis of 6-anhydro-1-thio-β-D-hexopyranose derivatives. Reagents and conditions: (a) Na2S·9H2O (2 equiv), CS2 (2 equiv), DMF, r.t. Using the same combination of reactants, the authors extended [69] the methodology to synthesize unsymmetrical glycosyl disulfides directly from glycosyl bromides by incorporating symmetrical disulfides. Under optimized conditions, a series of anomeric glycosyl bromides 54 were treated with symmetrical alkyl, aryl, and glycosyl disulfides, affording unsymmetrical β-glycosyl disulfides 106 in yields ranging from 72% to 90% (Scheme 26). Scheme 26. Synthesis of unsymmetrical glycosyl disulfides. Reagents and conditions: (a) CS2 (2 equiv.), Na2S·9H2O (2 equiv.), RSSR, DMF, 0 °C, rt, 5‒20 min. Scheme 26. Synthesis of unsymmetrical glycosyl disulfides. Reagents and conditions: (a) CS 2 (2 equiv.), Na2S·9H2O (2 equiv.), RSSR, DMF, 0 ◦C, rt, 5–20 min. 3. Se-Containing Carbohydrates The incorporation of selenium into organic frameworks has led to the development of potent bioactive compounds with antioxidant [ 70 ], antiviral [ 71 ], antiparasitic [ 72 ], anti-Alzheimer’s [ 73 – 75 ], or anticancer properties [ 76 – 80 ], among others. Combining the diverse biological activities of selenium with the unique structural features of carbohydrates offers a promising strategy for the design of novel drug candidates with enhanced therapeutic potential. 3.1. 4′- and 5′-Selenosugars Interest in replacing the endocyclic oxygen atom in carbohydrates by selenium dates back to the 1970’s. However, most early attempts were unsuccessful, either yielding undesired by-products, or producing the desired selenosugars in very low yields (e.g., derivative 107 (Figure 11) [ 81 ]. Later, Schiesser and co-workers, in the search for water-soluble antioxidants, pioneered [ 82 ] a more practical approach for synthesizing selenosugars (108–110). This was achieved through the thermolysis of per-O-bezylated-5-benzylseleno formates of D-ribo-, xyloand arabino-configurations. Their method involved an intramolecular attack of the benzylseleno scaffold, and elimination of CO2and phenylselenoate. To prepare reducing selenosugars, the same group reported [ 82 ] the SmI 2 -mediated transformation of O-protected 5-benzylseleno aldoses into derivatives 111–113 via an intramolecular homolytic substitution [ 83 ]. Nevertheless, only D-arabino-configured 113 was obtained in pure form and with moderate yield. Unfortunately, none of such compounds could be successfully deprotected. Liu and Pinto developed [ 84 ] a procedure for achieving unprotected selenofuranoses and pyranoses by using acetals as protecting groups in their efforts to synthesize selenonium sulfates as analogues of natural salacinol and kotalanol (Figure 2), potent α -glucosidase inhibitors. Their strategy for accessing the selenosugars was based on four steps: appropriate O-protection of the starting carbohydrate with isopropylidene groups, reduction of the latent aldehyde of the reducing sugar, di-O-mesylation and double nucleophilic displacement with in situ generated Na 2 Se (treatment of elemental selenium with the appropriate number of equivalents of NaBH 4 ), as depicted in Scheme 27 [ 84 ]. This simple synthetic Molecules 2025,30, 2053 20 of 54 pathway inspired Schiesser’s and other groups to access a wide variety of pyranoses and furanoses with diverse configurations. These included compounds like 114–116,118 [ 83 , 85 ], which are efficient scavengers of hypohalous acids and 117, a good mimetic of glutathione peroxidase (GPx) [86]. Molecules 2025, 30, x FOR PEER REVIEW 20 of 58 3. Se-Containing Carbohydrates The incorporation of selenium into organic frameworks has led to the development of potent bioactive compounds with antioxidant [70], antiviral [71], antiparasitic [72], antiAlzheimer’s [73–75], or anticancer properties [76–80], among others. Combining the diverse biological activities of selenium with the unique structural features of carbohydrates offers a promising strategy for the design of novel drug candidates with enhanced therapeutic potential. 3.1. 4′- and 5′-Selenosugars Interest in replacing the endocyclic oxygen atom in carbohydrates by selenium dates back to the 1970’s. However, most early attempts were unsuccessful, either yielding undesired by-products, or producing the desired selenosugars in very low yields (e.g., derivative 107 (Figure 11) [81]. Later, Schiesser and co-workers, in the search for water-soluble antioxidants, pioneered [82] a more practical approach for synthesizing selenosugars (108–110). This was achieved through the thermolysis of per-O-bezylated-5-benzylseleno formates of D-ribo-, xyloand arabino-configurations. Their method involved an intramolecular attack of the benzylseleno scaffold, and elimination of CO2 and phenylselenoate. To prepare reducing selenosugars, the same group reported [82] the SmI2-mediated transformation of O-protected 5-benzylseleno aldoses into derivatives 111–113 via an intramolecular homolytic substitution [83]. Nevertheless, only D-arabino-configured 113 was obtained in pure form and with moderate yield. Unfortunately, none of such compounds could be successfully deprotected. Figure 11. Structures of some of representative examples of selenosugars. Liu and Pinto developed [84] a procedure for achieving unprotected selenofuranoses and pyranoses by using acetals as protecting groups in their efforts to synthesize selenonium sulfates as analogues of natural salacinol and kotalanol (Figure 2), potent α-glucosidase inhibitors. Their strategy for accessing the selenosugars was based on four steps: appropriate O-protection of the starting carbohydrate with isopropylidene groups, reduction of the latent aldehyde of the reducing sugar, di-O-mesylation and double nucleophilic displacement with in situ generated Na2Se (treatment of elemental selenium with the appropriate number of equivalents of NaBH4), as depicted in Scheme 27 [84]. This simple synthetic pathway inspired Schiesser’s and other groups to access a wide variety of pyranoses and furanoses with diverse configurations. These included compounds like 114‒ Figure 11. Structures of some of representative examples of selenosugars. Molecules 2025, 30, x FOR PEER REVIEW 21 of 58 116, 118 [83,85], which are efficient scavengers of hypohalous acids and 117, a good mimetic of glutathione peroxidase (GPx) [86]. 119 OOH (HO)n MeO OMe acetone, PTSA ó OMe DMF, PTSA OOH OO (1) NaBH4 (2) MsCl OMs OMs OO 120 121 (1) Se, NaBH4 (2) TFA, CH2Cl2 122 Se (HO)n Scheme 27. General procedure for the preparation of unprotected selenosugars. Undoubtedly, due to its synthetic accessibility, the most extensively studied compound in this series is 1,4-anhydro-4-seleno-D-talitol (SeTal, 118, Figure 11). It has been considered as a privileged structure because of the diverse biological properties it exhibits. This water-soluble compound has demonstrated [87] potent scavenging activity against oxidizing agents, like HOCl and HOBr, the former being produced by the enzyme myeloperoxidase (MPO) to eliminate pathogens from inflamed tissues. Alongside other analogues with different configurations, SeTal and its derivatives have shown antioxidant potency up to twice that of their sulfur-counterparts. Moreover, 118 has been shown to repair damaged skin tissues in animal models, including diabetic wounds [87]. SeTal exhibits remarkable stability under acidic conditions (as those found when drugs have an oral administration) and also in artificial gastric or intestinal fluids, achieving steady-state intracellular concentrations ranging 2–10 µM. However, the exact internalization mechanism remains undetermined [88]. In vitro experiments have revealed that SeTal protects against oxidative damage in human coronary artery cells and mouse aortic rings [88]. Interestingly, topical application of 118 to induced skin injuries in mice modulated inflammatory markers [89]. Furthermore, its incorporation into gelatin and alginate polymeric films, either alone, or in combination with hydrocortisone or vitamin C, has recently shown promise as a treatment of atopic dermatitis [90]. Studies on its potential hepatotoxicity revealed [91] that SeTal only affects hepatic cells viability at very high concentrations, much higher than its potential therapeutic dose, making it a promising candidate for drug development. Another significant contribution to the field of water-soluble selenosugars was made by Iwaoka and Tomoda. They synthesized trans-dihydroxy selenonane 124 (DHSred) and diselenane 126 by nucleophilic opening of racemic 1,3-butadiene diepoxide with NaHSe or Na2Se2, respectively (Scheme 28) [92]. DHSred was shown to mimic the catalytic cycle of GPX by reducing H2O2 in the presence of a thiol-containing compound as a cofactor such as dithiothreitol (DTT) [93]. GPx is a metalloenzyme that maintains the homeostasis in Reactive Oxygen Species (ROS) levels by eliminating H2O2 and alkyl peroxides, with glutathione (GSH) as a cofactor. The proposed catalytic cycle in aqueous media involves the slow oxidation of DHSred with H2O2 to produce the selenoxide 128, which is subsequently reduced by DTT to give DSHred [93] (Scheme 29A). Scheme 27. General procedure for the preparation of unprotected selenosugars. Undoubtedly, due to its synthetic accessibility, the most extensively studied compound in this series is 1,4-anhydro-4-seleno-D-talitol (SeTal,118, Figure 11). It has been considered as a privileged structure because of the diverse biological properties it exhibits. This watersoluble compound has demonstrated [ 87 ] potent scavenging activity against oxidizing agents, like HOCl and HOBr, the former being produced by the enzyme myeloperoxidase (MPO) to eliminate pathogens from inflamed tissues. Alongside other analogues with different configurations, SeTal and its derivatives have shown antioxidant potency up to twice that of their sulfur-counterparts. Moreover, 118 has been shown to repair damaged skin tissues in animal models, including diabetic wounds [ 87 ]. SeTal exhibits remarkable stability under acidic conditions (as those found when drugs have an oral administration) and also in artificial gastric or intestinal fluids, achieving steady-state intracellular concentrations ranging 2–10 µ M. However, the exact internalization mechanism remains Molecules 2025,30, 2053 21 of 54 undetermined [ 88 ]. In vitro experiments have revealed that SeTal protects against oxidative damage in human coronary artery cells and mouse aortic rings [ 88 ]. Interestingly, topical application of 118 to induced skin injuries in mice modulated inflammatory markers [ 89 ]. Furthermore, its incorporation into gelatin and alginate polymeric films, either alone, or in combination with hydrocortisone or vitamin C, has recently shown promise as a treatment of atopic dermatitis [ 90 ]. Studies on its potential hepatotoxicity revealed [ 91 ] that SeTal only affects hepatic cells viability at very high concentrations, much higher than its potential therapeutic dose, making it a promising candidate for drug development. Another significant contribution to the field of water-soluble selenosugars was made by Iwaoka and Tomoda. They synthesized trans-dihydroxy selenonane 124 (DHS red ) and diselenane 126 by nucleophilic opening of racemic 1,3-butadiene diepoxide with NaHSe or Na 2 Se 2 , respectively (Scheme 28) [ 92 ]. DHS red was shown to mimic the catalytic cycle of GPX by reducing H 2 O 2 in the presence of a thiol-containing compound as a cofactor such as dithiothreitol (DTT) [ 93 ]. GPx is a metalloenzyme that maintains the homeostasis in Reactive Oxygen Species (ROS) levels by eliminating H 2 O 2 and alkyl peroxides, with glutathione (GSH) as a cofactor. The proposed catalytic cycle in aqueous media involves the slow oxidation of DHS red with H 2 O 2 to produce the selenoxide 128, which is subsequently reduced by DTT to give DSHred [93] (Scheme 29A). Molecules 2025, 30, x FOR PEER REVIEW 22 of 58 Scheme 28. Preparation of trans-dihydroxy selenonanes and diselenanes and lipophilic derivatives. Scheme 29. Catalytic cycles for the GPx-like activity of DHSred (A) and DSTox (B). DSHred exhibited superior ROS scavenging capacity compared to its non-cyclic isomer. The enhanced activity was attributed to increased HOMO energy due to the strain caused by the cyclic structure [94], facilitating oxidation. Unexpectedly, when GPx-like activity was tested in MeOH, the reaction became much more complex. Over-oxidized species, like hydroxyselenonium and hydroxy perhydroxyselane were suggested to play an active role in the scavenging process [95]. DHSred also demonstrated [96] radio-protective effects in mice when administrated intraperitoneally before and after the irradiation with 60Co. Reduced DNA damage, decreased lipid peroxidation, and down-regulation of pro-inflammatory genes were observed [96]. These effects were similar to those exhibited by the seleno-amino acid SeMet. The mechanism included GPx-dependent DNA repair enhancement [97]. Monoesterification of DHSred with acid chlorides derived from propionic, lauric, myristic, palmitic, and stearic acids yielded fatty acid conjugates (125), with lipid peroxide Scheme 28. Preparation of trans-dihydroxy selenonanes and diselenanes and lipophilic derivatives. DSH red exhibited superior ROS scavenging capacity compared to its non-cyclic isomer. The enhanced activity was attributed to increased HOMO energy due to the strain caused by the cyclic structure [ 94 ], facilitating oxidation. Unexpectedly, when GPx-like activity was tested in MeOH, the reaction became much more complex. Over-oxidized species, like hydroxyselenonium and hydroxy perhydroxyselane were suggested to play an active role in the scavenging process [95]. DHS red also demonstrated [ 96 ] radio-protective effects in mice when administrated intraperitoneally before and after the irradiation with 60 Co. Reduced DNA damage, decreased lipid peroxidation, and down-regulation of pro-inflammatory genes were observed [ 96 ]. These effects were similar to those exhibited by the seleno-amino acid SeMet. The mechanism included GPx-dependent DNA repair enhancement [97]. Monoesterification of DHS red with acid chlorides derived from propionic, lauric, myristic, palmitic, and stearic acids yielded fatty acid conjugates (125), with lipid peroxide (LOOH) scavenging activity in lecithin/cholesterol liposome membranes [ 98 ]. The myristate derivative displayed interfacial redox activity. Amphiphilic diselenides (127) were also synthesized [99]. Molecules 2025,30, 2053 22 of 54 Molecules 2025, 30, x FOR PEER REVIEW 22 of 58 Scheme 28. Preparation of trans-dihydroxy selenonanes and diselenanes and lipophilic derivatives. Scheme 29. Catalytic cycles for the GPx-like activity of DHSred (A) and DSTox (B). DSHred exhibited superior ROS scavenging capacity compared to its non-cyclic isomer. The enhanced activity was attributed to increased HOMO energy due to the strain caused by the cyclic structure [94], facilitating oxidation. Unexpectedly, when GPx-like activity was tested in MeOH, the reaction became much more complex. Over-oxidized species, like hydroxyselenonium and hydroxy perhydroxyselane were suggested to play an active role in the scavenging process [95]. DHSred also demonstrated [96] radio-protective effects in mice when administrated intraperitoneally before and after the irradiation with 60Co. Reduced DNA damage, decreased lipid peroxidation, and down-regulation of pro-inflammatory genes were observed [96]. These effects were similar to those exhibited by the seleno-amino acid SeMet. The mechanism included GPx-dependent DNA repair enhancement [97]. Monoesterification of DHSred with acid chlorides derived from propionic, lauric, myristic, palmitic, and stearic acids yielded fatty acid conjugates (125), with lipid peroxide Scheme 29. Catalytic cycles for the GPx-like activity of DHSred (A) and DSTox (B). Diselenides such as 127 (Scheme 28) were shown [ 100 ] to mimic protein disulfide isomerases (PDIs), enzymes critical for redox homeostasis in the endoplasmic reticulum and in the prevention of amyloid plaque pathogenicity. Furthermore, GPx-like activity was observed for 126 and 127. Depending on their hydrophilic (R = H, C3) or hydrophobic (R = C6–C14) nature, GPx1or GPx4-like activity predominated [ 99 ], respectively. These compounds reduced H 2 O 2 or lipid peroxides (LOOH) to harmless H 2 O and an alcohol (LOH), respectively (Scheme 29B). Antioxidant properties were also confirmed in cultured cells [ 99 ]. A similar behavior was proposed for DHSred (124) and monoesters counterparts (125) [101]. Mugesh and co-workers described [ 102 ] the synthesis of enantiomerically pure transdihydroxy diselenide (126) and selenyl sulfide (136) as antioxidants to protect erythrocytes (RBCs, Red Blood Cells) from oxidative stress-induced eryptosis (programmed RBC death). The synthesis involved treatment of 1,4-di-O-tosyl-2,3-O-isopropylidene-L-threitol 131 with substoichiometric selenol 133 (obtained by reduction of p-methoxybenzyl diselenide 132) to give benzyl selenide 134. Subsequent nucleophilic displacement of the second tosylate with KSAc, followed by I 2 -mediated oxidation afforded O-protected selenyl sulfide 135 (Scheme 30). Final deprotection under acidic conditions furnished 136. Alternatively, treatment of ditosylated 131 with an excess of selenol 133 gave the dibenzylselenide 137. Final oxidation and deprotection led to the expected diselenide 126 [102]. When RBCs were exposed to H 2 O 2 to simulate severe oxidative stress, treatment with 126 and 127 reduced ROS levels, demonstrating effective antioxidant activity in cells. Structural aspects proved critical; decreasing conformational flexibility (via isopropilidene protection) or replacing selenium atoms with sulfur impaired activity [ 102 ]. O-protected derivatives exhibited high toxicity, even without H 2 O 2 . Inhibition of glutathione reductase (GR), leading to reduced glutathione (GSH) levels, significantly diminished the protective effects of 126 and 136. This confirmed that their antioxidant activity primarily relies on GPx-like mechanisms, with GSH as a cofactor [102]. Molecules 2025,30, 2053 23 of 54 Molecules 2025, 30, x FOR PEER REVIEW 23 of 58 (LOOH) scavenging activity in lecithin/cholesterol liposome membranes [98]. The myristate derivative displayed interfacial redox activity. Amphiphilic diselenides (127) were also synthesized [99]. Diselenides such as 127 (Scheme 28) were shown [100] to mimic protein disulfide isomerases (PDIs), enzymes critical for redox homeostasis in the endoplasmic reticulum and in the prevention of amyloid plaque pathogenicity. Furthermore, GPx-like activity was observed for 126 and 127. Depending on their hydrophilic (R = H, C3) or hydrophobic (R = C6‒C14) nature, GPx1or GPx4-like activity predominated [99], respectively. These compounds reduced H2O2 or lipid peroxides (LOOH) to harmless H2O and an alcohol (LOH), respectively (Scheme 29B). Antioxidant properties were also confirmed in cultured cells [99]. A similar behavior was proposed for DHSred (124) and monoesters counterparts (125) [101]. Mugesh and co-workers described [102] the synthesis of enantiomerically pure transdihydroxy diselenide (126) and selenyl sulfide (136) as antioxidants to protect erythrocytes (RBCs, Red Blood Cells) from oxidative stress-induced eryptosis (programmed RBC death). The synthesis involved treatment of 1,4-di-O-tosyl-2,3-O-isopropylidene-L-threitol 131 with substoichiometric selenol 133 (obtained by reduction of p-methoxybenzyl diselenide 132) to give benzyl selenide 134. Subsequent nucleophilic displacement of the second tosylate with KSAc, followed by I2-mediated oxidation afforded O-protected selenyl sulfide 135 (Scheme 30). Final deprotection under acidic conditions furnished 136. Alternatively, treatment of ditosylated 131 with an excess of selenol 133 gave the dibenzylselenide 137. Final oxidation and deprotection led to the expected diselenide 126 [102]. OTs OTs O O OMe Se Se MeO NaBH4 DMF SeH MeO 131 132 133 OTs SePMB O O 134 (1) KSAc 18-crown-6 (2) KOH, EtOH SH SePMB O O 135 (0.95 equiv.) 133 (2.1 equiv.) (1) I2 (2) p-TsOH X Se HO HO SePMB SePMB O O 137 (1) I2 (2) p-TsOH 126 (X = Se) 136 (X = S) Scheme 30. Synthesis of trans-dihydroxy diselenide 126 and selenenyl sulfide 136. When RBCs were exposed to H2O2 to simulate severe oxidative stress, treatment with 126 and 127 reduced ROS levels, demonstrating effective antioxidant activity in cells. Structural aspects proved critical; decreasing conformational flexibility (via isopropilidene protection) or replacing selenium atoms with sulfur impaired activity [102]. O-protected derivatives exhibited high toxicity, even without H2O2. Inhibition of glutathione reductase (GR), leading to reduced glutathione (GSH) levels, significantly diminished the protective effects of 126 and 136. This confirmed that their antioxidant activity primarily relies on GPx-like mechanisms, with GSH as a cofactor [102]. Selenosugars have been conjugated with hydroxycinnamic acids, known for their potent antioxidant agents, via a Mitsunobu reaction to achieve synergic effects [103]. Initially, the authors intended [104] to use L-sugars (the C-4 epimer of 139), obtained from Dribose through a 6-step synthetic pathway: isopropylidene protection of the C-2 and C-3 Scheme 30. Synthesis of trans-dihydroxy diselenide 126 and selenenyl sulfide 136. Selenosugars have been conjugated with hydroxycinnamic acids, known for their potent antioxidant agents, via a Mitsunobu reaction to achieve synergic effects [ 103 ]. Initially, the authors intended [ 104 ] to use L-sugars (the C-4 epimer of 139), obtained from D-ribose through a 6-step synthetic pathway: isopropylidene protection of the C-2 and C-3 positions, TBDPS protection at C-5, reduction of latent aldehyde, di-O-mesylation, nucleophilic displacement with NaHSe and acidic removal of TBDPS protecting group. However, unexpectedly, when the C-4 epimer of 139 was subjected to the Mitsunobu reaction with monoaceytlated hydroquinone, a configurational inversion occurred at C-4, resulting in aD-sugar instead [ 104 ]. Alternatively, D-configured selenosugar 139 can be obtained in a 5-step methodology starting from O-protected D-ribonolactone 138 [ 104 ]: mesylation of C-5 position, inversion of configuration on C-4 promoted by KOH, TBDPS-protection of C-5, reduction of the lactone moiety, di-O-mesylation, nucleophilic displacement with NaHSe, and C-5 deprotection. Subsequently, p-coumaric, caffeic and feluric acids were attached to the free OH at C-5 through a Mitsunobu reaction (giving compounds 140–142) [ 103 , 104 ], in the presence of diisopropyl azodicarboxilate (DIAD) and PPh3(Scheme 31). Final deprotection of the isopropylidene protecting group under acidic conditions afforded conjugates 143–145. These conjugates exhibited notable free-radical scavenging properties, reduced toxicity at concentrations up to 100 µ M, and promising wound-healing properties in keratinocytes ( in vitro scratch wound model), making them potential cosmeceutical ingredients [ 103 , 104 ]. Unprotected derivatives 144 and 145, derived from p-caffeic and ferulic acids, demonstrated dose-dependent healing activity, at lower doses compared to the corresponding unconjugated cinnamic acids. The authors did not find a correlation between a higher cellular uptake and the wound healing properties, suggesting interaction with outer cell membrane components [103]. Using a similar approach with the C-4-epimer of 139, conjugate 146 was synthesized [ 105 ] using diacetylated resveratrol in a Mitsunobu-type reaction (Scheme 31). transResveratrol, a natural phytoalexina found in grapes and red wine, exhibits numerous biological properties like antioxidant, anti-inflammatory, cardioand neuroprotective, and antidiabetic effects [ 106 ]. Caffeic acid and resveratrol conjugates 144 and 146 were loaded on a hydroxyl film to develop a pH-sensitive delivery system for accelerating skin wound healing. For this purpose, a copolymer comprised of poly(ethyleneglycol diacrylate) (PEGDA) and poly(hydroxyethyl methacrylate) (HEMA), in a 1:4.2 molar ratio, was used. Compound 144 was released at pH 7.4, suitable for acute wounds, whereas resveratrol-containing 146 was released at pH 9.6, optimal for chronic wounds [ 105 ]. The Molecules 2025,30, 2053 24 of 54 pH-depending selective release was attributed to weak interactions between the selenoconjugates and the hydroxyl groups of HEMA [105]. Molecules 2025, 30, x FOR PEER REVIEW 24 of 58 positions, TBDPS protection at C-5, reduction of latent aldehyde, di-O-mesylation, nucleophilic displacement with NaHSe and acidic removal of TBDPS protecting group. However, unexpectedly, when the C-4 epimer of 139 was subjected to the Mitsunobu reaction with monoaceytlated hydroquinone, a configurational inversion occurred at C-4, resulting in a D-sugar instead [104]. Alternatively, D-configured selenosugar 139 can be obtained in a 5-step methodology starting from O-protected D-ribonolactone 138 [104]: mesylation of C-5 position, inversion of configuration on C-4 promoted by KOH, TBDPS-protection of C-5, reduction of the lactone moiety, di-O-mesylation, nucleophilic displacement with NaHSe, and C-5 deprotection. Subsequently, p-coumaric, caffeic and feluric acids were attached to the free OH at C-5 through a Mitsunobu reaction (giving compounds 140‒142) [103,104], in the presence of diisopropyl azodicarboxilate (DIAD) and PPh3 (Scheme 31). Scheme 31. Preparation of selenosugar-phenolic acid conjugates through a Mitsunobu reaction. Final deprotection of the isopropylidene protecting group under acidic conditions afforded conjugates 143‒145. These conjugates exhibited notable free-radical scavenging properties, reduced toxicity at concentrations up to 100 µM, and promising wound-healing properties in keratinocytes (in vitro scratch wound model), making them potential cosmeceutical ingredients [103,104]. Unprotected derivatives 144 and 145, derived from p-caffeic and ferulic acids, demonstrated dose-dependent healing activity, at lower doses compared to the corresponding unconjugated cinnamic acids. The authors did not find a correlation between a higher cellular uptake and the wound healing properties, suggesting interaction with outer cell membrane components [103]. Using a similar approach with the C-4-epimer of 139, conjugate 146 was synthesized [105] using diacetylated resveratrol in a Mitsunobu-type reaction (Scheme 31). transResveratrol, a natural phytoalexina found in grapes and red wine, exhibits numerous biological properties like antioxidant, anti-inflammatory, cardioand neuroprotective, and antidiabetic effects [106]. Caffeic acid and resveratrol conjugates 144 and 146 were loaded on a hydroxyl film to develop a pH-sensitive delivery system for accelerating skin wound healing. For this purpose, a copolymer comprised of poly(ethyleneglycol diacrylate) (PEGDA) and poly(hydroxyethyl methacrylate) (HEMA), in a 1:4.2 molar ratio, Scheme 31. Preparation of selenosugar-phenolic acid conjugates through a Mitsunobu reaction. The same group recently developed [ 107 ] a second generation of selenosugar-cinnamic acid conjugates as cosmeceutical agents, introducing an acetoxy group at the pseudoanomeric position to enhance cellular uptake. This structural feature was incorporated via a seleno-Pummerer rearrangement of selenoxide 148 upon heating in Ac 2 O (Scheme 32). This reaction has been used extensively by Iwaoka’s group for accessing selenonucleosides [ 108 ] (see Section 3.2). Subsequent silyl-O-deprotection, followed by Mitsunobu reaction with the same phenolic acids as described in Scheme 32, and final O-deprotection furnished conjugates 151–153. Compared to the first generation counterparts, the acetoxy derivatives 151–153 displayed a dose-dependent cytotoxicity, potentially affecting mitochondria redox activity at concentrations above 25 µ M [ 107 ]. Among these, 153 exhibited a 7.5-fold increase in cell membrane permeability compared to 145, which lacks the acetoxy group (HaCaT cells). The caffeoyl derivative 152 showed the strongest protective effect against H 2 O 2 , while selenosugars derived from p-coumaric and ferulic acids (151 and 153) demonstrated pro-oxidant properties. Using a percutaneous absorption assay, first generation compounds, without the acetoxy group, generally exhibited higher skin penetration [ 107 ]. Compound 144 displayed the fastest penetration rate. However, 152 (derived from caffeic acid) was the only secondgeneration compound found in the receptor fluid layer. Molecules 2025,30, 2053 25 of 54 Molecules 2025, 30, x FOR PEER REVIEW 25 of 58 was used. Compound 144 was released at pH 7.4, suitable for acute wounds, whereas resveratrol-containing 146 was released at pH 9.6, optimal for chronic wounds [105]. The pH-depending selective release was attributed to weak interactions between the selenoconjugates and the hydroxyl groups of HEMA [105]. The same group recently developed [107] a second generation of selenosugarcinnamic acid conjugates as cosmeceutical agents, introducing an acetoxy group at the pseudo-anomeric position to enhance cellular uptake. This structural feature was incorporated via a seleno-Pummerer rearrangement of selenoxide 148 upon heating in Ac2O (Scheme 32). This reaction has been used extensively by Iwaoka’s group for accessing selenonucleosides [108] (see Section 3.2). Subsequent silyl-O-deprotection, followed by Mitsunobu reaction with the same phenolic acids as described in Scheme 32, and final O-deprotection furnished conjugates 151‒153. Scheme 32. Preparation of the second-generation selenosugar-phenolic acid conjugates. Compared to the first generation counterparts, the acetoxy derivatives 151‒153 displayed a dose-dependent cytotoxicity, potentially affecting mitochondria redox activity at concentrations above 25 µM [107]. Among these, 153 exhibited a 7.5-fold increase in cell membrane permeability compared to 145, which lacks the acetoxy group (HaCaT cells). The caffeoyl derivative 152 showed the strongest protective effect against H2O2, while selenosugars derived from p-coumaric and ferulic acids (151 and 153) demonstrated pro-oxidant properties. Using a percutaneous absorption assay, first generation compounds, without the acetoxy group, generally exhibited higher skin penetration [107]. Compound 144 displayed the fastest penetration rate. However, 152 (derived from caffeic acid) was the only second-generation compound found in the receptor fluid layer. 3.2. Selenonucleosides The incorporation of selenium into nucleosides has been proposed as a strategy to modulate or enhance their anticancer or antiviral properties [10]. Herein we focused specifically on replacing the endocyclic oxygen atom in the carbohydrate moiety with selenium. Previous studies exploring selenium substitution within the nitrogen base have been comprehensively reviewed [10]. Scheme 32. Preparation of the second-generation selenosugar-phenolic acid conjugates. 3.2. Selenonucleosides The incorporation of selenium into nucleosides has been proposed as a strategy to modulate or enhance their anticancer or antiviral properties [ 10 ]. Herein we focused specifically on replacing the endocyclic oxygen atom in the carbohydrate moiety with selenium. Previous studies exploring selenium substitution within the nitrogen base have been comprehensively reviewed [10]. Most reported examples of selenonucleosides describe the synthesis of the 4 ′ - selenosugar moiety 154 via a double nucleophilic displacement reaction using in situ generated NaHSe on a di-O-mesylated derivative, as illustrated in Scheme 27. Subsequently, the nitrogen base is usually introduced into the selenosugar framework through two main strategies (Scheme 33). Pathway A: treatment of a selenoxide (155) directly with a silylated nitrogen base in the presence of TMSOTf and Et 3 N. Pathway B: via selenoPummerer rearrangement with Ac 2 O followed by N-glycosylation with a nitrogen base (Vorbrüggen glycosylation). In this approach, the selenoxide undergoes heating in the presence of Ac 2 O to produce the acetoxy derivative 157, that acts as the glycosyl donor. The acetoxy intermediates then react with the appropriate nitrogen base in the presence of N,O-bis(trimethylsilyl)acetamide (BSA) and TMSOTf (Scheme 33). Molecules 2025, 30, x FOR PEER REVIEW 26 of 58 Most reported examples of selenonucleosides describe the synthesis of the 4′-selenosugar moiety 154 via a double nucleophilic displacement reaction using in situ generated NaHSe on a di-O-mesylated derivative, as illustrated in Scheme 27. Subsequently, the nitrogen base is usually introduced into the selenosugar framework through two main strategies (Scheme 33). Pathway A: treatment of a selenoxide (155) directly with a silylated nitrogen base in the presence of TMSOTf and Et3N. Pathway B: via seleno-Pummerer rearrangement with Ac2O followed by N-glycosylation with a nitrogen base (Vorbruggen glycosylation). In this approach, the selenoxide undergoes heating in the presence of Ac2O to produce the acetoxy derivative 157, that acts as the glycosyl donor. The acetoxy intermediates then react with the appropriate nitrogen base in the presence of N,O-bis(trimethylsilyl)acetamide (BSA) and TMSOTf (Scheme 33). Scheme 33. General procedure for the preparation of selenonucleosides. In the search for novel anti hepatitis C virus agents (HCV), Jeong and co-workers prepared Se-analogues of Sofosbuvir, an oral drug that is prescribed for the treatment of chronic HCV [109]. It was claimed that the presence of selenium might increase the lipophilicity compared to the 4′-oxo nucleosides, thus enabling these compounds to be transported across cell membranes; furthermore, the bulkier character of the selenium atom can also affect the nucleoside conformation [109]. Commercially available 2-C-methyl-Dribono-γ-lactone 158 was transformed into the key 4′-selenofuranose 159 in a 5-step procedure, which included basic-promoted epimerization at C-4′ and nucleophilic displacement of a transient di-O-mesylate by selenide as the key steps. Then, two families of selenonucleosides were obtained [109] from 159 (Scheme 34): 4′-selenopyrimidine and purine nucleosides. The former family (161‒163) was obtained following the pathway A of Scheme 33; MCPBA-promoted oxidation of 159 to give the glycosyl donor 160 followed by treatment with the appropriate pyrimidine base, TMSOTf and Et3N furnished the corresponding O-protected nucleosides in a roughly 1:2.5 α:β ratio [109]. Deprotection afforded derivatives 161‒163 (Scheme 34). Scheme 33. General procedure for the preparation of selenonucleosides. Molecules 2025,30, 2053 32 of 54 generated selenide and primary O-deprotection. The nucleobase was introduced in this case via an S N 2 reaction prior mesylation of 204 [ 120 ]. Again, the best compound in the series within 205 incorporated a Cl atom at C-2 and a 3-iodobenzyl moiety at N 6 . This compound behaved as a potent PPAR γ partial agonist (Ki = 2.8 µ M) and a PPAR δ antagonist (Ki = 43 nM). Additionally, it improved the production of adiponectin, a hormone secreted for controlling the metabolism of fatty acids and glucose, increasing sensitivity to insulin. This effect demonstrates that the synergic modulation of both receptors can lead to promising agents for the treatment of metabolic disorders, specifically those associated with hypoadiponectinemia [120]. Molecules 2025, 30, x FOR PEER REVIEW 32 of 58 of the Skp2 (S-Phase Kinase Associated Protein 2) expression in PC-3-Pa cells, a hitherto unknown target for selenonucleosides [117]. Figure 14. Structure of the anticancer selenonucleoside LJ-2618. A template that has been extensively studied is 4′-selenoadenosine in connection with peroxisome proliferator-activated and A3 adenosine receptors (PPAR and A3AR, respectively). PPARs (classified as PPARα, γ and δ, depending on the tissue distribution and specific function), have a key role in maintaining the metabolic homeostasis, with a direct involvement in the metabolism of lipids and glucose, adipogenesis, and also in inflammatory responses [118]. Accordingly, PPARs are interesting therapeutic targets for metabolic disorders and inflammatory diseases, like inflammatory bowel disease. Jeon, Noh and co-workers developed a series of selenoadenosine nucleosides (203, Figure 15) by modification of the substituents at C-2 (H, Cl) and C-6 positions N6-(cycloalkyl, aryl, halobenzyl) of the base [119]. Interestingly, derivative 203, decorated with a Cl atom at C2 and a 3-iodobenzyl moiety at N6 exhibited an enhanced antagonist activity against PPARδ compared to its 4′-oxo and 4′-thio counterparts. This behaviour was attributed to the unusual South conformation; docking simulations confirmed additional hydrogen bonding within the hydrophobic pocket of the enzyme, what was lacking in its other chalcogen isosters [119]. Figure 15. Structure of 5′-N-methylcarbamoyl-4′-selenoadenosines and truncated/homologated analogues. Figure 15. Structure of 5 ′ -N-methylcarbamoyl-4 ′ -selenoadenosines and truncated/homologated analogues. Bioisosteric replacement of oxygen and sulfur in previous nucleosides by selenium led to A 3 AR agonists, a feature that can allow the development of new drugs for the treatment of inflammatory and autoimmune diseases. In this context, derivative 205 bearing a H at H-2 and a N 6 -3-iodobenzyl moiety (Figure 15), behaved as a subnanomolar agonist of such receptor (K i = 0.57 nM) [ 121 ]. This represents an outstanding selectivity compared to A 1 AR and A 3 AR (selectivity index > 800 and 1900, respectively). Structural analysis revealed that these selenonucleosides exhibit again a South furanose puckering, and a syn orientation of the nucleobase; surprisingly, previous A 3 AR agonist exhibit the complete opposite conformational preference. The lead compound also showed an improved inhibition of the MCP-1 induced microglial chemotaxis, suggesting potential anti-stroke properties [121]. Further Structure-Activity studies conducted on adenosine receptors led to the preparation of selenonucleosides 206, with a truncated structure [ 122 ], and 207 [ 123 ], with a disubstituted nitrogen atom on the carboxamido motif (Figure 15). Compounds 206 exhibited strong binding to A3AR, within the nanomolar range. Surprisingly, the two most potent compounds (R 1 = Cl) incorporated alkyl groups on R 2 positions (Me and cycloalkyl, K i = 5.2 and 5.7 nM). Computational calculations demonstrated that the South puckering of the carbohydrate residue allowed a closer location within the binding site of OH-3 to Thr94, compared to 4 ′ -oxo nucleosides [ 122 ]. Furthermore, an agonist effect was observed, unlike their truncated oxygen and sulfur counterparts, which behaved as antagonist of this receptor. Molecules 2025,30, 2053 33 of 54 Remarkably, the addition of a second methyl to the carboxamido moiety (207) shifted the activity of the 4-‘selenonucleosides to antagonism, with medium to high binding affinity [ 123 ]. The best compounds lacked a chlorine atom at the 2-position of the nucleobase, and the lead one was decorated with a 3-iodobenzyl scaffold at N 6 -position (K i = 22.7 nM). The same behaviour, and similar binding affinities were found for isosteric 4 ′ -oxo and 4 ′ -thionucleosides. Theoretical calculations revealed the essential role of the NH moiety for exhibiting agonist activity [123]. 3.3. Selenoglycosides The substitution of the oxygen atom in the glycosidic bond with selenium has emerged as a prominent strategy in glycomimetic synthesis. This isosteric modification enables the development of biomimetics with enhanced metabolic stability compared to their natural counterparts, while maintaining dynamic and conformational properties similar to those of thioglycosides [ 124 ]. Selenoglycosides, through 77 Se-NMR, X-ray crystallography or calorimetry titrations, are widely used in structural studies [ 124 – 127 ], particularly for gaining deeper insights into carbohydrate recognition by protein receptors, such as lectins. Notable examples of these glycomimetics include the selenoand diselenodiglycosides 208–210 [124,126,127], which have been studied for their binding to human galectins 1and 3, as well as Se-sialoside 211, a mimetic of sialyl α (2,6) and α (2,3)-galactose epitopes, relevant for investigating glycan-pathogen interactions (Figure 16). Numerous selenoglycosides also exhibit relevant biological properties; for instance, Comini and co-workers evaluated [ 128 ] an ample panel of selenoglycosides as potential antiparasitic agents against trypanosomiasis; the lead compounds exhibited activity within the submicromolar range, and good selectivity. Molecules 2025, 30, x FOR PEER REVIEW 34 of 58 similar to those of thioglycosides [124]. Selenoglycosides, through 77Se-NMR, X-ray crystallography or calorimetry titrations, are widely used in structural studies [124–127], particularly for gaining deeper insights into carbohydrate recognition by protein receptors, such as lectins. Notable examples of these glycomimetics include the selenoand diselenodiglycosides 208‒210 [124,126,127], which have been studied for their binding to human galectins 1and 3, as well as Se-sialoside 211, a mimetic of sialyl α(2,6) and α(2,3)- galactose epitopes, relevant for investigating glycan-pathogen interactions (Figure 16). Numerous selenoglycosides also exhibit relevant biological properties; for instance, Comini and co-workers evaluated [128] an ample panel of selenoglycosides as potential antiparasitic agents against trypanosomiasis; the lead compounds exhibited activity within the submicromolar range, and good selectivity. Figure 16. Representative selenoglycosides for structural studies. The growing interest in selenoglycosides has driven the need for practical and stereoselective synthetic methods. Most of these approaches are based on nucleophilic displacements carried out by Se-based nucleophiles (Scheme 41) on glycosyl halides (212), triflates, acetates (215) and glycals (216). For instance, the treatment of glycosyl halides with p-methylselenobenzoic anhydride in the presence of Cs2CO3 and piperidine, generates p-methylselenobenzoate in situ, which then undergoes a SN2 reaction at the anomeric position, with inversion of configuration, yielding p-methylbenzoylselenoglycoside 213 (Scheme 41, pathway A). Further reaction with alkyl halides, including those containing sugar residues, under basic conditions enables the preparation of the corresponding selenoglycosides [125,129]. Using this methodology as one of the key steps, Murphy and coworkers accomplished [129] the preparation of 219 (Figure 17), the Se-isoster of the immunostimulant α-GalCer. In their synthetic pathway, TiCl4 was used to isomerize an equatorial β-selenoglycoside into its axial α-counterpart. Figure 17. Relevant selenoglycosides. Figure 16. Representative selenoglycosides for structural studies. The growing interest in selenoglycosides has driven the need for practical and stereoselective synthetic methods. Most of these approaches are based on nucleophilic displacements carried out by Se-based nucleophiles (Scheme 41) on glycosyl halides (212), triflates, acetates (215) and glycals (216). For instance, the treatment of glycosyl halides with p-methylselenobenzoic anhydride in the presence of Cs 2 CO 3 and piperidine, generates pmethylselenobenzoate in situ, which then undergoes a S N 2 reaction at the anomeric position, with inversion of configuration, yielding p-methylbenzoylselenoglycoside 213 (Scheme 41, pathway A). Further reaction with alkyl halides, including those containing sugar residues, under basic conditions enables the preparation of the corresponding selenoglycosides [ 125 , 129 ]. Using this methodology as one of the key steps, Murphy and coworkers accomplished [ 129 ] the preparation of 219 (Figure 17), the Se-isoster of the immunostimulant α -GalCer. In their synthetic pathway, TiCl 4 was used to isomerize an equatorial β-selenoglycoside into its axial α-counterpart. Molecules 2025,30, 2053 34 of 54 Molecules 2025, 30, x FOR PEER REVIEW 35 of 58 O n(RO) SeR O n(AcO) OAc 10% InBr3 Phenyl 1,2-transselenoglycosides O n(RO) X (1) KSeCN (2) NaBH4 Ac2O X = Br, I Y = Br, I, OTf R: Alkyl, glycosyl O n(RO) SeAc RY Pyrrolidine High stereoselectivity (RSe)2 NH2-NH2 KOH O n(RO) Br R-SeCN NaBH4 ó NaBH4 O Ph2Se2 TMSN3 BAIB R=Ph O n(BnO) BF3K (PhSe)2 Blue LED R=Ph Ir N N N NtBu tBu F F F3C F F CF3PF6Photocatalyst Photocatalyst O Se O Piperidine, CsCO3 O n(RO) Se H3CCH3 O CH3R-X A B C D O n(RO) SnBu3 CuCl, KF (RSe)2 Ph-SeH E F G 212 213 214 212 215 216 217 218 Cs2CO3, piperazine H Azido-phenyl selenation reaction Scheme 41. Main synthetic procedures for the preparation of selenoglycosides. A transient p-methylselenobenzoate intermediate was also used [130] in cross-coupling reactions by treatment with heteroaryl and alkenyl halides using a Pd-based catalyst (PdG3 XantPhos) under mild conditions. This process furnished the unprecedented formation of a C(sp2)-Se bond, like in 220 (Figure 17). This methodology proved to be compatible with a variety of functional groups, including aldehydes, ketones, or nitriles, among others. However, it was claimed [131] that, despite being an elegant approach, it lacks atom economy, as the acyl moiety in 213 is not incorporated into the final structure. This issue was overcome by Liang and coworkers by using modified conditions of the Castellani reaction (Scheme 42), originally envisioned for the synthesis of arenes, and based on Pd/norbornene (NBE) cooperative catalysis [132]. They reported the unprecedented use of two-component Castallani-type reaction for coupling p-methylbenzoylselenoglycosides 213 with (hetero)aryl iodides to furnish selenoglycosides upon formation of a new C(sp2)-Se bond, and concomitant Se‒C(=O) breaking. A similar procedure was also employed for accessing the corresponding thioisosters. This strategy proved to have a broad scope, being effective in O-protected pyranoses and furanoses (ribose, glucose, mannose, galactose, xylose, arabinose), including disaccharides like cellobiose and maltose, and tolerates a variety of functional groups (Ac, Piv, Bn, TBDPS, Me). A tentative catalytic cycle (adapted from the one reported for thioglycosides) is illustrated in Scheme 42. (Pd(MeCN)2Cl2 is used as the Pd(II) source, and P(p-Cl-C6H4)3 as the ligand; the formation of the selenoglycoside is postulated to take place through seven steps [131]: oxidative addition of Pd(0) into aryl iodides, migratory insertion of 5-norbornene-2-carbonitrile, ortho C-H activation to give the five-membered palladacycle 227, oxidative addition of p-methylbenzoylselenoglycoside 213, reductive elimination, norbornene extrusion, and a second reductive elimination to give selenoglycoside 231, where no loss of atoms has taken place. The main concerns of this approach are the high temperatures (95–100 °C) and the long reaction times (16 h). Scheme 41. Main synthetic procedures for the preparation of selenoglycosides. Molecules 2025, 30, x FOR PEER REVIEW 34 of 58 similar to those of thioglycosides [124]. Selenoglycosides, through 77Se-NMR, X-ray crystallography or calorimetry titrations, are widely used in structural studies [124–127], particularly for gaining deeper insights into carbohydrate recognition by protein receptors, such as lectins. Notable examples of these glycomimetics include the selenoand diselenodiglycosides 208‒210 [124,126,127], which have been studied for their binding to human galectins 1and 3, as well as Se-sialoside 211, a mimetic of sialyl α(2,6) and α(2,3)- galactose epitopes, relevant for investigating glycan-pathogen interactions (Figure 16). Numerous selenoglycosides also exhibit relevant biological properties; for instance, Comini and co-workers evaluated [128] an ample panel of selenoglycosides as potential antiparasitic agents against trypanosomiasis; the lead compounds exhibited activity within the submicromolar range, and good selectivity. Figure 16. Representative selenoglycosides for structural studies. The growing interest in selenoglycosides has driven the need for practical and stereoselective synthetic methods. Most of these approaches are based on nucleophilic displacements carried out by Se-based nucleophiles (Scheme 41) on glycosyl halides (212), triflates, acetates (215) and glycals (216). For instance, the treatment of glycosyl halides with p-methylselenobenzoic anhydride in the presence of Cs2CO3 and piperidine, generates p-methylselenobenzoate in situ, which then undergoes a SN2 reaction at the anomeric position, with inversion of configuration, yielding p-methylbenzoylselenoglycoside 213 (Scheme 41, pathway A). Further reaction with alkyl halides, including those containing sugar residues, under basic conditions enables the preparation of the corresponding selenoglycosides [125,129]. Using this methodology as one of the key steps, Murphy and coworkers accomplished [129] the preparation of 219 (Figure 17), the Se-isoster of the immunostimulant α-GalCer. In their synthetic pathway, TiCl4 was used to isomerize an equatorial β-selenoglycoside into its axial α-counterpart. Figure 17. Relevant selenoglycosides. Figure 17. Relevant selenoglycosides. A transient p-methylselenobenzoate intermediate was also used [ 130 ] in cross-coupling reactions by treatment with heteroaryl and alkenyl halides using a Pd-based catalyst (PdG3 XantPhos) under mild conditions. This process furnished the unprecedented formation of a C(sp 2 )-Se bond, like in 220 (Figure 17). This methodology proved to be compatible with a variety of functional groups, including aldehydes, ketones, or nitriles, among others. However, it was claimed [ 131 ] that, despite being an elegant approach, it lacks atom economy, as the acyl moiety in 213 is not incorporated into the final structure. This issue was overcome by Liang and coworkers by using modified conditions of the Castellani reaction (Scheme 42), originally envisioned for the synthesis of arenes, and based on Pd/norbornene (NBE) coop- Molecules 2025,30, 2053 35 of 54 erative catalysis [ 132 ]. They reported the unprecedented use of two-component Castallanitype reaction for coupling p-methylbenzoylselenoglycosides 213 with (hetero)aryl iodides to furnish selenoglycosides upon formation of a new C(sp 2 )-Se bond, and concomitant Se– C(=O) breaking. A similar procedure was also employed for accessing the corresponding thioisosters. This strategy proved to have a broad scope, being effective in O-protected pyranoses and furanoses (ribose, glucose, mannose, galactose, xylose, arabinose), including disaccharides like cellobiose and maltose, and tolerates a variety of functional groups (Ac, Piv, Bn, TBDPS, Me). A tentative catalytic cycle (adapted from the one reported for thioglycosides) is illustrated in Scheme 42. (Pd(MeCN) 2 Cl 2 is used as the Pd(II) source, and P(p-Cl-C 6 H 4 ) 3 as the ligand; the formation of the selenoglycoside is postulated to take place through seven steps [ 131 ]: oxidative addition of Pd(0) into aryl iodides, migratory insertion of 5-norbornene-2-carbonitrile, ortho C-H activation to give the five-membered palladacycle 227, oxidative addition of p-methylbenzoylselenoglycoside 213, reductive elimination, norbornene extrusion, and a second reductive elimination to give selenoglycoside 231, where no loss of atoms has taken place. The main concerns of this approach are the high temperatures (95–100 ◦C) and the long reaction times (16 h). Azeem and Mandal described [ 133 ] the atom-economic and gram-scale synthesis of unsymmetrical gem-diarylmethyl(thio)seleno glycosides. For this purpose, glycosyl thio(seleno) acetates and other acylated derivatives 232 (analogues to 213) were treated with Cs 2 CO 3 and p-quinone methides (p-QMs). It was hypothesized that Cs 2 CO 3 promotes the cleavage of the X-C(=O) bond, generating a transient thiolate/selenolate that undergoes a 1,6-addition on the p-QMs and an acyl transfer via a concerted mechanism (Scheme 43). Reactions proceeded smoothly (rt), with short reaction times (30 min-2 h), and the selenoglycosides 233 were isolated in a roughly 1:1 diasteromeric ratio. 1,2-trans-Selenoglycosides (alkyl, aryl, glycosyl) can be obtained [ 134 ] through the nucleophilic attack of selenides (Scheme 41, Pathway B), which are generated via the reductive cleavage of symmetrical diselenides. These selenides then react with per-Oacetylated glycosyl bromides under phase transfer catalysis. Using a similar approach, Oscarson and coworkers reported [ 135 ] the preparation of selenoglycosides bearing a fluorine atom as useful tools for studying protein-carbohydrate interactions with 19 F and 77Se-NMR spectroscopy. Another approach to prepare selenoglycosides from glycosyl halides 212 is illustrated in Scheme 41, Pathway C. Treatment with KSeCN affords glycosyl selenocyanates, typically with inversion of configuration. Reduction of the selenocyanato motif with NaBH 4 generates a configurationally stable selenide, which is subsequently trapped through acetylation (214). Further reaction with alkyl halides under basic conditions leads to the formation of the corresponding selenoglycoside [ 136 ] in good yields, and short reaction times (10–20 min). Disaccharides, like 221, were also obtained with this procedure. Glycosyl bromides 212 were also treated with aryl selenides, generated via the NaBH 4 - mediated reduction of the corresponding aryl selenocyanates (Scheme 41, Pathway D). This strategy was used by Angeli and coworkers [ 137 ] to develop novel sulfonamides bearing a selenoglycoside linkage, like 222, designed for targeting seizures associated with glucose transporter type 1 deficiency syndrome (GLUT1-DS). Reactions involving Se-based nucleophiles can also take place in per-O-acetylated aldoses, using benzene selenol and InBr 3 as a moisture-stable Lewis acid (Scheme 41, Pathway E) [ 138 ]. This strategy affords 1,2-trans selenoglycosides, due to neighbouring group participation, in moderate to almost quantitative yields. The methodology is also applicable to the preparation of phenyl thioglycosides. Molecules 2025,30, 2053 36 of 54 Molecules 2025, 30, x FOR PEER REVIEW 36 of 58 Scheme 42. Catalytic cycle of the Castellani-type reaction for the synthesis of (hetero)aryl selenoglycosides. Azeem and Mandal described [133] the atom-economic and gram-scale synthesis of unsymmetrical gem-diarylmethyl(thio)seleno glycosides. For this purpose, glycosyl thio(seleno) acetates and other acylated derivatives 232 (analogues to 213) were treated with Cs2CO3 and p-quinone methides (p-QMs). It was hypothesized that Cs2CO3 promotes the cleavage of the X-C(=O) bond, generating a transient thiolate/selenolate that undergoes a 1,6-addition on the p-QMs and an acyl transfer via a concerted mechanism (Scheme 43). Reactions proceeded smoothly (rt), with short reaction times (30 min-2 h), and the selenoglycosides 233 were isolated in a roughly 1:1 diasteromeric ratio. Scheme 42. Catalytic cycle of the Castellani-type reaction for the synthesis of (hetero)aryl selenoglycosides. Nifantiev and coworkers reported [ 139 ] the heterogeneous and reproducible 2-azidophenylselenylation of 3,5,6-tri-O-acetyl-D-galactal with Ph 2 Se 2 and TMSN 3 (Scheme 41, Pathway F) in the presence of the hypervalent iodine compound BAIB (PhI(OAc) 2 , [bis(acetoxy)iodo]benzene). This reaction afforded crystalline phenyl 3,4,6-tri-O-acetyl2-azido-2-deoxy-1-selenoα -D-galactopyranoside (223), used for the preparation of galactosamine building blocks. Conversely, the use of D-glucal did not proceed with stereoselectivity, resulting in a mixture of D-gluco and D-manno selenoglycosides. The use of flow chemistry allowed a reduction of side-products, and the reaction time, compared to the batch process [ 140 ]; optimised conditions led to the production of the above 2-azidoselenoglycoside in 1.2 mmol/h rate, affording the processing of 5 mmol of galactal over a 3 h-period. Alternatively, Walczak and coworkers reported the stereoretentive synthesis of selenoglycosides starting from glycosyl tributyl stannanes and symmetrical diselenides in the Molecules 2025,30, 2053 37 of 54 presence of CuCl and KF (Scheme 41, Pathway G) [ 141 ]. No directing groups are required, and the reaction proceeds successfully with free hydroxyl groups (e.g., 224), affording a broad scope that enabled the preparation of a vast library of compounds. It was hypothesized that the tributyl stannane undergoes a stereoretentive transmetallation reaction with CuCl, enabled by the presence of F − . Then, the glycosyl organocopper intermediate reacts with the diselenide, collapsing to the corresponding selenoglycoside [ 141 ]. The main limitations are the temperatures (110 ◦C) and hazardous organotin reagents. Molecules 2025, 30, x FOR PEER REVIEW 37 of 58 Scheme 43. Preparation of unsymmetrical gem-diarylmethylthio(seleno)glycosides. 1,2-trans-Selenoglycosides (alkyl, aryl, glycosyl) can be obtained [134] through the nucleophilic attack of selenides (Scheme 41, Pathway B), which are generated via the reductive cleavage of symmetrical diselenides. These selenides then react with per-O-acetylated glycosyl bromides under phase transfer catalysis. Using a similar approach, Oscarson and coworkers reported [135] the preparation of selenoglycosides bearing a fluorine atom as useful tools for studying protein-carbohydrate interactions with 19F and 77Se-NMR spectroscopy. Another approach to prepare selenoglycosides from glycosyl halides 212 is illustrated in Scheme 41, Pathway C. Treatment with KSeCN affords glycosyl selenocyanates, typically with inversion of configuration. Reduction of the selenocyanato motif with NaBH4 generates a configurationally stable selenide, which is subsequently trapped through acetylation (214). Further reaction with alkyl halides under basic conditions leads to the formation of the corresponding selenoglycoside [136] in good yields, and short reaction times (10‒20 min). Disaccharides, like 221, were also obtained with this procedure. Glycosyl bromides 212 were also treated with aryl selenides, generated via the NaBH4-mediated reduction of the corresponding aryl selenocyanates (Scheme 41, Pathway D). This strategy was used by Angeli and coworkers [137] to develop novel sulfonamides bearing a selenoglycoside linkage, like 222, designed for targeting seizures associated with glucose transporter type 1 deficiency syndrome (GLUT1-DS). Reactions involving Se-based nucleophiles can also take place in per-O-acetylated aldoses, using benzene selenol and InBr3 as a moisture-stable Lewis acid (Scheme 41, Pathway E) [138]. This strategy affords 1,2-trans selenoglycosides, due to neighbouring group participation, in moderate to almost quantitative yields. The methodology is also applicable to the preparation of phenyl thioglycosides. Nifantiev and coworkers reported [139] the heterogeneous and reproducible 2-azidophenylselenylation of 3,5,6-tri-O-acetyl-D-galactal with Ph2Se2 and TMSN3 (Scheme 41, Scheme 43. Preparation of unsymmetrical gem-diarylmethylthio(seleno)glycosides. The same group recently developed a procedure for the stereoretentive cross-coupling reaction of 2-deoxysugars bearing anomeric trifluoroborates. The main targets were Carylation and etherification reactions under photoredox conditions (via a single electron transfer mechanism) [ 142 ]. As the only example of a selenoglycoside, they described the preparation of phenyl 2-deoxy-3,4,6-tri-O-benzylα -D-glucopyranoside with total retention of configuration (Scheme 41, Pathway H). Corzana and coworkers reported [ 143 ] the preparation of Sand Se-mimetics of a GalNAc glycopeptide (compound 238, Scheme 44) derived from mucin MUC1, an Oglycoprotein overexpressed in a series of tumours. This glycopeptide acts as a tumourassociated antigen, and thus, is potentially useful in the development of cancer vaccines. The substitution of oxygen by bulkier S and Se atoms increases the distance between the saccharide residue and the oligopeptide, and also alters the orientation of the glycosidic bond. These structural modifications allowed the glycopeptide 238 and its sulfur isoster to adopt a pre-organized conformation that improved binding to the MUC1 antibody [ 143 ]. The preparation of selenoglycoside 237, a key synthetic intermediate latter subjected to solid-phase peptide synthesis, involved a nucleophilic displacement exerted by a selenium nucleophile (Scheme 44). Unlike previous examples, in this case the diselenide motif was located at the anomeric position. This was achieved starting from per-O-acetylated GalNAc, Molecules 2025,30, 2053 38 of 54 which upon treatment with Woolin’s reagent afforded a transient selenoamide that evolved to bicyclic 2-methylselenazoline 235 through a spontaneous intramolecular nucleophilic cyclization. Subsequent treatment with TFA furnished diselenide 236 which was then reduced and coupled to an iodinated derivative of L-threonine [143]. Molecules 2025, 30, x FOR PEER REVIEW 39 of 58 Scheme 44. Synthesis of Se-GalNAc-glycopeptide as a tumour-associated antigen. Scheme 45. Use of selenoglycosides in glycosylation reactions. Alternatively, Li and co-workers converted the 2-azido functionality in 239 (O-benzyl protected) into 2-deoxy-2-(2,4-dinitrobenzenesulfonyl)amino (DNsNH) (compound 241, Scheme 45) [146], which in turn can be treated with thioacetic acid and DMAP to give an acetamido motif. Activation of 2-deoxy-2-DNsNH phenyl selenoglycoside 241 with a combination of PhSeCl and AgOTf, followed by the addition of the glycosyl acceptor at low temperatures afforded disaccharide 242 with good β-stereoselectivity. This protocol proved to be efficient even with sterically hindered glycosyl acceptors, with reduced nucleophilic properties. The combination of 241 with sequential thioglycoside-based donors enabled the preparation of β-(1→6)-linked triand hexasaccharides with potential interest as antigens in the search for vaccines against microbial infections [146]. Scheme 44. Synthesis of Se-GalNAc-glycopeptide as a tumour-associated antigen. Selenoglycosides are not only relevant for structural studies or for the development of bioactive compounds, but they are also valuable intermediates in organic synthesis, as they can be used as glycosyl donors with different alcohols (including partially protected saccharides) and promoters. This strategy has also been used in the preparation of complex oligosaccharides [ 144 ]. Phenyl α -selenoglycosides, obtained via an azido-phenyl selenation reaction from glycals as depicted in Scheme 41 (Pathway F) were activated using classical glycosylation conditions with NIS and TMSOTf, and treated with either primary or secondary (sugar-derived) alcohols (Scheme 45); in the latter case, disaccharides were obtained [ 145 ]. 2-Azido motifs are the precursors of amino and acetamido scaffolds, present in numerous bioactive glycans. When D-gluco-configured selenoglycosides were used (e.g., 240), a good α : β selectivity was observed (3–5:1); interestingly, mannopyranosides afforded α-linked glycosides exclusively. Alternatively, Li and co-workers converted the 2-azido functionality in 239 (O-benzyl protected) into 2-deoxy-2-(2,4-dinitrobenzenesulfonyl)amino (DNsNH) (compound 241, Scheme 45) [ 146 ], which in turn can be treated with thioacetic acid and DMAP to give an acetamido motif. Activation of 2-deoxy-2-DNsNH phenyl selenoglycoside 241 with a combination of PhSeCl and AgOTf, followed by the addition of the glycosyl acceptor at low temperatures afforded disaccharide 242 with good β -stereoselectivity. This protocol proved to be efficient even with sterically hindered glycosyl acceptors, with reduced nucleophilic properties. The combination of 241 with sequential thioglycoside-based donors enabled the preparation of β -(1 → 6)-linked triand hexasaccharides with potential interest as antigens in the search for vaccines against microbial infections [146]. Molecules 2025,30, 2053 39 of 54 Molecules 2025, 30, x FOR PEER REVIEW 39 of 58 Scheme 44. Synthesis of Se-GalNAc-glycopeptide as a tumour-associated antigen. Scheme 45. Use of selenoglycosides in glycosylation reactions. Alternatively, Li and co-workers converted the 2-azido functionality in 239 (O-benzyl protected) into 2-deoxy-2-(2,4-dinitrobenzenesulfonyl)amino (DNsNH) (compound 241, Scheme 45) [146], which in turn can be treated with thioacetic acid and DMAP to give an acetamido motif. Activation of 2-deoxy-2-DNsNH phenyl selenoglycoside 241 with a combination of PhSeCl and AgOTf, followed by the addition of the glycosyl acceptor at low temperatures afforded disaccharide 242 with good β-stereoselectivity. This protocol proved to be efficient even with sterically hindered glycosyl acceptors, with reduced nucleophilic properties. The combination of 241 with sequential thioglycoside-based donors enabled the preparation of β-(1→6)-linked triand hexasaccharides with potential interest as antigens in the search for vaccines against microbial infections [146]. Scheme 45. Use of selenoglycosides in glycosylation reactions. 3.4. Miscellaneous Selenosugars Other sugar mimetics containing selenium have been reported, besides selenosugars, selenonucleosides and selenoglycosides. Figure 18 shows some recent examples of such structures. Thus, López and co-workers reported [ 74 ] the preparation of sugar-derived bicyclic 1,3-selenazolines bearing either an alkylamino (243) or alkoxy (244) residue at the C-2 position of the heterocyclic motif. Such structures were designed as dual inhibitors of cholinesterases and O-GlcNAcase (OGA), two enzymes that are considered as validated targets against Alzheimer’s disease; it was postulated that the presence of a Se atom might contribute to maintain the redox homeostasis. Derivatives 243, and particular the derivative with R = Pr exhibited the best bioactivities. This compound acted as a submicromolar selective inhibitor of butyrylcholinesterase (predominant in advanced stages of the disease; IC 50 = 0.46 µ M) and a nanomolar selective inhibitor of human OGA (IC 50 = 53 nM), while showing no significant activity against glycosidases or cytotoxicity [74]. Fan’s group designed prodrugs derived from the antitumour drug gemcitabine and a 1,2-diselenolane moiety connected through a carbamate linker (Se-Gem,245, Figure 18) [147]. This compound, which acted as a suicide prodrug, improved the antiproliferative activity of gemcitabine (up to 6-fold, IC 50 = 0.11–0.88 µ M). It was activated by glutathione (GSH), releasing gemcitabine and the diselenide, depleting GSH and increasing the oxidative stress, what in turn induced cell-death by apoptosis [147]. Using O-protected monosaccharides decorated with a selenocyanato motif either at C-4 or C-6 position, Misra’s group accomplished the preparation of non-symmetrical and non-glycosidic pseudodisaccharides connected through a selenide (246) [ 148 ] or a diselenide (247) [ 149 ] tether (Figure 18). In both cases, the key step is the reduction of the selenocyanato group with hydrazine hydrate to give a transient and reactive sugar selenide, which traps a sugar iodide or triflate to 246, or a symmetrical sugar diselenide to give 247. Additionally, treatment of a 6-iodo sugar derivative with a symmetrical sugar diselenide, CS 2 and Na 2 S · 9H 2 O afforded a pseudo disaccharide with a S-Se linkage (e.g., 248) [ 150 ]. When the leaving group is located on the anomeric position (acetobromo aldoses), reaction Molecules 2025,30, 2053 40 of 54 with sugar diselenides afforded compounds like 249, with exclusive formation of the β-anomer. This methodology proved to be scalable, odourless and high-yielding [150]. Molecules 2025, 30, x FOR PEER REVIEW 40 of 58 3.4. Miscellaneous Selenosugars Other sugar mimetics containing selenium have been reported, besides selenosugars, selenonucleosides and selenoglycosides. Figure 18 shows some recent examples of such structures. Thus, López and co-workers reported [74] the preparation of sugar-derived bicyclic 1,3-selenazolines bearing either an alkylamino (243) or alkoxy (244) residue at the C-2 position of the heterocyclic motif. Such structures were designed as dual inhibitors of cholinesterases and O-GlcNAcase (OGA), two enzymes that are considered as validated targets against Alzheimer’s disease; it was postulated that the presence of a Se atom might contribute to maintain the redox homeostasis. Derivatives 243, and particular the derivative with R = Pr exhibited the best bioactivities. This compound acted as a submicromolar selective inhibitor of butyrylcholinesterase (predominant in advanced stages of the disease; IC50 = 0.46 µM) and a nanomolar selective inhibitor of human OGA (IC50 = 53 nM), while showing no significant activity against glycosidases or cytotoxicity [74]. Figure 18. Miscellaneous selenosugars. Fan’s group designed prodrugs derived from the antitumour drug gemcitabine and a 1,2-diselenolane moiety connected through a carbamate linker (Se-Gem, 245, Figure 18) [147]. This compound, which acted as a suicide prodrug, improved the antiproliferative activity of gemcitabine (up to 6-fold, IC50 = 0.11‒0.88 µM). It was activated by glutathione (GSH), releasing gemcitabine and the diselenide, depleting GSH and increasing the oxidative stress, what in turn induced cell-death by apoptosis [147]. Using O-protected monosaccharides decorated with a selenocyanato motif either at C-4 or C-6 position, Misra’s group accomplished the preparation of non-symmetrical and non-glycosidic pseudodisaccharides connected through a selenide (246) [148] or a diselenide (247) [149] tether (Figure 18). In both cases, the key step is the reduction of the selenocyanato group with hydrazine hydrate to give a transient and reactive sugar selenide, which traps a sugar iodide or triflate to 246, or a symmetrical sugar diselenide to give 247. Additionally, treatment of a 6-iodo sugar derivative with a symmetrical sugar diselenide, CS2 and Na2S·9H2O afforded a pseudo disaccharide with a S-Se linkage (e.g., 248) [150]. When the leaving group is located on the anomeric position (acetobromo alFigure 18. Miscellaneous selenosugars. 4. Te-Containing Carbohydrates Tellurium was first identified by von Reichstein in 1782, while the synthesis of the first organotellurium compounds (dialkyl tellurides) was achieved in 1840 by Wöher [ 151 ]. However, significant advances in the field of organotellurium chemistry did not occur until the 1980s, roughly a decade after organoselenium chemistry did [ 152 ]. This delay can be attributed to the fact that low-molecular weight organotellurium derivatives are typically volatile, malodorous and perceived as toxic substances [ 152 ]. Initially considered as an extension of Se-containing isomers, organotellurium chemistry has since unlocked new synthetic possibilities [ 153 ]. The synthesis and applications of organotellurium derivatives are currently being explored in a wide range of areas, including organoand metal-based catalysis [ 154 , 155 ], biocatalysts [ 156 ], Material Science [ 157 – 159 ], and Medicinal Chemistry [160,161], among others. 4.1. Tellurosugars When it comes to carbohydrate mimetics, the number of tellurium-containing saccharides is significantly smaller compared to their thioand seleno counterparts. In these derivatives, tellurium has been incorporated in different positions of the carbohydrate skeleton, such as the endocyclic position, the aglycon residue, or other specific sites, like the C-5 position of xylofuranoses (protecting agents against oxidative stress in in vivo experiments) [162], or C-2 and C-6 positions of cyclodextrins (as GPx mimics) [163]. Inspired by the promising antioxidant properties of selenosugars, Schiesser and coworkers reported [ 11 , 164 ] the preparation of isosteric 4-tellurofuranoses (252,255,257–259), 5-telluropyranoses 260–262 and 6-tellurepane 256 as water soluble carbohydrate mimics. These compounds were accessed using naturally occurring carbohydrates with different configuration as starting materials. They key step of their syntheses involved a double nucleophilic substitution reaction on dimesylated alditols (e.g., 250,253,254) exerted by freshly prepared NaHTe (Scheme 46). NaHTe was in turn obtained by reducing elemental Te Molecules 2025,30, 2053 41 of 54 with NaBH 4 . The nucleophilic displacement reaction was found to proceed more efficiently when polytethylene glycol (PEG-400) was used as solvent. Additionally, the choice of the protecting group played a crucial role in the outcome of the reaction. Whereas Obenzylated tellurosugars 260–262 could not be deprotected [ 164 ] to yield the corresponding unprotected carbohydrate mimics, acetals were successfully removed upon treatment with TFA. 5-Telluropyranose 260 was found to be highly unstable, even when preserved in the freezer, and spontaneously underwent decomposition, with release of elemental Te; in order to demonstrate the formation of 260, it was transformed into dibromotellurium derivative 261, upon reaction with Br2. Molecules 2025, 30, x FOR PEER REVIEW 42 of 58 D-Mannose OMs O OOMs H O O Te + NaBH4 NaHTe Te OO H O O PEG-400 TFA H2OCH2Cl2 Te HO OH H HO OH 250 251 252 (34% from 250) D-Galactose OMs O OOMs H O O 253 + OMs MsO O O O O Te HO OH H HO OH 255 (32% from 253) 254 Te OH HO OH HO 256 (53% from 254) Te HO OH H HO OH 257 (from L-mannose) Te HO OH H HO OH 258 (from D-gulonic acid 1,4lactone, unstable) Te HO OH H HO 259 (from 2,3-di-O-isopropylideneD-ribonic acid 1,4-lactone) X OBn OBn BnO 260 (X = Te) (from D-arabinose) 261 (X = TeBr2) Te OBn OBn BnO 262 (from L-arabinose) Br2 Scheme 46. Preparation of tellurosugars by nucleophilic substitution on di-O-mesylalditols. Additionally, racemic trans-3,4-dihydroxy-1-tellurolane 263 was obtained [11] in almost quantitative yield by nucleophilic reaction of buta-1,3-diene bisepoxide 123 with aq. NaHTe (Scheme 47). Alternatively, Capperucci and coworkers reported [165] the synthesis of 263 under on water conditions and using rongalite (sodium hydroxymethanesulfinate) to reduce in situ elemental Te to Na2Te as the nucleophile (Scheme 47). Compound 263 is the Te-isoster of DHSred 124, a selenosugar mimetics endowed with strong antioxidant properties, as considered in the precedent section. Scheme 47. Preparation of trans-3,4-dihydroxy-1-tellurolane 263. Tellurosugars 252, 256, 257, 259 and 263 were assayed [11] for their scavenging properties against common oxidant agents like hypochlorous, hypobromous and peroxynitrous acids (HOCl, HOBr and ONOOH, respectively), generated by the inflammatory enzyme myeloperoxidase. Antioxidant properties against HOCl and HOBr were determined using a competition kinetics assay, while stopped-flow spectroscopy was used for Scheme 46. Preparation of tellurosugars by nucleophilic substitution on di-O-mesylalditols. Additionally, racemic trans-3,4-dihydroxy-1-tellurolane 263 was obtained [ 11 ] in almost quantitative yield by nucleophilic reaction of buta-1,3-diene bisepoxide 123 with aq. NaHTe (Scheme 47). Alternatively, Capperucci and coworkers reported [ 165 ] the synthesis of 263 under on water conditions and using rongalite (sodium hydroxymethanesulfinate) to reduce in situ elemental Te to Na 2 Te as the nucleophile (Scheme 47). Compound 263 is the Te-isoster of DHS red 124, a selenosugar mimetics endowed with strong antioxidant properties, as considered in the precedent section. Tellurosugars 252,256,257,259 and 263 were assayed [ 11 ] for their scavenging properties against common oxidant agents like hypochlorous, hypobromous and peroxynitrous acids (HOCl, HOBr and ONOOH, respectively), generated by the inflammatory enzyme myeloperoxidase. Antioxidant properties against HOCl and HOBr were determined using a competition kinetics assay, while stopped-flow spectroscopy was used for monitoring reaction with ONOOH. 3,4-Dihydroxy-1-tellurolane 263 exhibited the best antioxidant profile against HOCl and ONOOH, whereas 4-tellurofuranose 259 was the best scavenger Molecules 2025,30, 2053 48 of 54 21. Morikawa, T.; Ninomiya, K.; Tanabe, G.; Matsuda, H.; Yoshikawa, M.; Muraoka, O. A review of antidiabetic active thiosugar sulfoniums, salacinol and neokotalanol, from plants of the genus Salacia.J. Nat. Med. 2021,75, 449–466. [CrossRef] 22. Takashima, K.; Sakano, M.; Kinouchi, E.; Nakamura, S.; Marumoto, S.; Ishikawa, F.; Ninomiya, K.; Nakanishi, I.; Morikawa, T.; Tanabe, G. Elongation of the side chain by linear alkyl groups increases the potency of salacinol, a potent α -glucosidase inhibitor from the Ayurvedic traditional medicine “Salacia”, against human intestinal maltase. Bioorg. Med. Chem. Lett. 2021,33, 127751. [CrossRef] [PubMed] 23. Takashima, K.; Nakamura, S.; Nagayama, M.; Marumoto, S.; Ishikawa, F.; Xie, W.; Nakanishi, I.; Muraoka, O.; Morikawa, T.; Tanabe, G. Role of the thiosugar ring in the inhibitory activity of salacinol, a potent natural α -glucosidase inhibitor. RSC Adv. 2024,14, 4471–4481. [CrossRef] [PubMed] 24. Fowler, P.A.; Haines, A.H.; Taylor, R.J.K.; Chrystal, E.J.T.; Gravestock, M.B. Synthesis and biological activity of acyclic analogues of nojirimycin. J. Chem. Soc. Perkin Trans. 1 1994,1, 2229–2235. [CrossRef] 25. Ishikawa, F.; Jinno, K.; Kinouchi, E.; Ninomiya, K.; Marumoto, S.; Xie, W.; Muraoka, O.; Morikawa, T.; Tanabe, G. Diastereoselective synthesis of salacinol-type α-glucosidase inhibitors. J. Org. Chem. 2018,83, 185–193. [CrossRef] 26. Crawford, C.J.; Seeberger, P.H. Advances in glycoside and oligosaccharide synthesis. Chem. Soc. Rev. 2023,52, 7773–7801. [CrossRef] 27. Bennai, N.; Chabrier, A.; Fatthalla, M.I.; Tran, C.; Yen-Pon, E.; Belkadi, M.; Alami, M.; Grimaud, L.; Messaoudi, S. Reversing reactivity: Stereoselective desulfurative 1,2-trans-O-glycosylation of anomeric thiosugars with carboxylic acids under copper or cobalt catalysis. J. Org. Chem. 2020,85, 8893–8909. [CrossRef] 28. Banisalman, K.A.F.; Polykandritou, A.; Barnieh, F.M.; Morais, G.R.; Falconer, R.A. Chemoselective solutionand solid-phase synthesis of disulfide linked glycopeptides. J. Org. Chem. 2022,87, 14026–14036. [CrossRef] 29. Neralkar, M.; Tian, L.; Redman, R.L.; Krauss, I.J. Synthesis of mannosidase-stable Man 3 and Man 4 glycans containing S-linked Manα1→2Man termini. Org. Lett. 2021,23, 3053–3057. [CrossRef] 30. Morrone-Pozzuto, P.; Uhrig, M.L.; Agusti, R. Synthesis of oligosaccharides containing the S-Galp( α 1 → 3)Galp unit, glycomimetic of the epitope recognized by lytic antibodies. J. Org. Chem. 2022,87, 13455–13468. [CrossRef] 31. Bege, M.; Singh, V.; Sharma, N.; Debreczeni, N.; Bereczki, I.; Poonam; Herczegh, P.; Rathi, B.; Singh, S.; Borbás, A. In vitro and in vivo antiplasmodial evaluation of sugar-modified nucleoside analogues. Sci. Rep. 2023,13, 12228. [CrossRef] 32. Azzam, R.A.; Gad, N.M.; Elgemeie, G.H. Novel thiophene thioglycosides substituted with the benzothiazole moiety: Synthesis, characterization, antiviral and anticancer evaluations, and NS3/4A and USP7 enzyme inhibitions. ACS Omega 2022,7, 35656–35667. [CrossRef] 33. de la Luz Quintana, I.; Paul, A.; Chowdhury, A.; Moulton, K.D.; Kulkarni, S.S.; Dube, D.H. Thioglycosides act as metabolic inhibitors of bacterial glycan biosynthesis. ACS Infect. Dis. 2023,9, 2025–2035. [CrossRef] [PubMed] 34. Wang, S.-S.; Gao, X.; del Solar, V.; Yu, X.; Antonopoulos, A.; Friedman, A.E.; Matich, E.K.; Atilla-Gokcumen, G.E.; Nasirikenari, M.; Lau, J.T.; et al. Thioglycosides are efficient metabolic decoys of glycosylation that reduce selectin dependent leukocyte adhesion. Cell Chem. Biol. 2018,25, 1519–1532. [CrossRef] 35. He, P.; Zhang, X.; Xia, K.; Green, D.E.; Baytas, S.; Xu, Y.; Pham, T.; Liu, J.; Zhang, F.; Almond, A.; et al. Chemoenzymatic synthesis of sulfur-linked sugar polymers as heparanase inhibitors. Nat. Commun. 2022,13, 7438. [CrossRef] 36. Burrini, N.; Pâris, A.; Collet, G.; Lafite, P.; Daniellou, R. Biocatalytic synthesis of coumarin S-glycosides: Towards non-cytotoxic probes for biomedical imaging and sensing. Molecules 2024,29, 1322. [CrossRef] 37. Ferrara, I.; Chesnokov, G.A.; Dittmann, S.; Blacque, O.; Sievers, S.; Gademann, K. Formal single atom editing of the glycosylated natural product fidaxomicin improves acid stability and retains antibiotic activity. JACS Au 2024,4, 2267–2280. [CrossRef] 38. Chen, J.-S.; Lo, T.-C.; Hsieh, Y.-C.; Chen, C.-H.; Lin, M.; Lin, H.-Y.; Hung, M.-W.; Wu, H.-R.; Luo, S.-Y. Utilizing reusable catalyst phosphotungstic acid for the synthesis of thioglycoside from per-O-acetyl saccharides with microwave assisted and de-O-acetylation with methanol. ACS Omega 2023,8, 8885–8893. [CrossRef] 39. Feng, G.-J.; Luo, T.; Guo, Y.-F.; Liu, C.-Y.; Dong, H. Concise synthesis of 1-thioalkyl glycoside donors by reaction of per-Oacetylated sugars with sodium alkanethiolates under solvent-free conditions. J. Org. Chem. 2022,87, 3638–3646. [CrossRef] 40. Santos, B.F.; Silva, B.A.L.; Domingues, N.L.C. Pd-catalyzed functionalization of benzo-2,1,3-thiadiazole at the C-5-position using 1-thiosugars. New, J. Chem. 2022,46, 19785–19789. [CrossRef] 41. Bennai, N.; Ibrahim, N.; Marrot, J.; Belkadi, M.; Alami, M.; Magnier, E.; Anselmi, E.; Messaoudi, S. Synthesis of S-trifluoromethyl S-arylsulfoximine thioglycosides through Pd-catalyzed Migita cross-coupling. Eur. J. Org. Chem. 2020,2020, 4972–4981. [CrossRef] 42. Wu, Y.; Zhou, W.-J.; Yao, L.; Niu, Y.; Zhao, H.; Peng, C.; Han, B.; Huang, W.; Zhan, G. Organocatalytic atroposelective synthesis of naphthoquinone thioglycosides from aryl-naphthoquinones and thiosugars. Chem. Commun. 2023,59, 7279–7282. [CrossRef] [PubMed] 43. Dubey, A.; Mandal, P.K. An Efficient one-pot protocol for direct access to diarylmethyl thioglycosides with para-quinone methides via S-glycosyl isothiouronium salts. Synlett 2020,31, 1713–1719. [CrossRef] Molecules 2025,30, 2053 49 of 54 44. Venkatesh, R.; Tiwari, V.; Kandasamy, J. Copper(I)-catalyzed Sandmeyer-type S-arylation of 1-thiosugars with aryldiazonium salts under mild conditions. J. Org. Chem. 2022,87, 11414–11432. [CrossRef] [PubMed] 45. Feng, G.-J.; Guo, Y.-F.; Tang, Y.; Li, M.; Jia, Y.; Li, Z.; Wang, S.; Liu, H.; Wu, Y.; Dong, H. Design, synthesis, and biological evaluation of thioglucoside analogues of gliflozin as potent new gliflozin drugs. J. Med. Chem. 2023,66, 12536–12543. [CrossRef] 46. Feng, G.-J.; Wang, S.-S.; Lv, J.; Luo, T.; Wu, Y.; Dong, H. Improved synthesis of 1-glycosyl thioacetates and its application in the synthesis of thioglucoside gliflozin analogues. Eur. J. Org. Chem. 2021,2021, 2940–2949. [CrossRef] 47. Li, S.; Wang, Y.; Zhong, L.; Wang, S.; Liu, Z.; Dai, Y.; He, Y.; Feng, Z. Boron-promoted umpolung reaction of sulfonyl chlorides for the stereospecific synthesis of thioglycosides via reductive deoxygenation coupling reactions. Org. Lett. 2022,24, 2463–2468. [CrossRef] 48. Malapit, C.A.; Prater, M.B.; Cabrera-Pardo, J.R.; Li, M.; Pham, T.D.; McFadden, T.P.; Blank, S.; Minteer, S.D. Advances on the merger of electrochemistry and transition metal catalysis for organic synthesis. Chem. Rev. 2022,122, 3180–3218. [CrossRef] 49. Li, F.; Liu, H.; Xing, W.; Zhang, Q.; Wang, L. Electrochemical nickel-catalyzed cross-coupling of glycosyl thiols with preactivated phenols and ketones. Org. Biomol. Chem. 2024,22, 3597–3601. [CrossRef] 50. Zhu, M.; Alami, M.; Messaoudi, S. Electrochemical nickel-catalyzed Migita cross-coupling of 1-thiosugars with aryl, alkenyl and alkynyl bromides. Chem. Commun. 2020,56, 4464–4467. [CrossRef] 51. Wang, R.-Q.; Jiang, Q.-H.; Wang, H.-X.; Zhang, X.-W.; Yan, N. Electrochemically mediated S-glycosylation of 1-thiosugars with xanthene derivatives. Org. Lett. 2023,25, 4252–4257. [CrossRef] 52. Zhu, M.; Ghouilem, J.; Messaoudi, S. Visible-light-mediated Stadler − Ziegler arylation of thiosugars with anilines. ACS Org. Inorg. Au. 2022,2, 351–358. [CrossRef] [PubMed] 53. Fang, Y.; Liang, Q.; Shi, L.; Wen, J.; Liu, X.; Hong, X.; Zha, X.; Ji, F. Site-selective S-arylation of 1-thiosugars with aryl thianthrenium salts through copper(I)-mediated, photoredox catalyzed reactions. Adv. Synth. Catal. 2024,36, 2344–2351. [CrossRef] 54. Zhang, L.; He, S.; Hou, J.; Ye, M.; Chen, J.; Lv, G.; Huang, T.; Yang, Z.; Wu, Y. Visible-light-mediated synthesis of non-anomeric S-aryl glycosides via a photoactive electron-donor–acceptor complex. Chem. Commun. 2023,59, 13759–13762. [CrossRef] 55. Belmonte-Reche, E.; Benassi, A.; Peñalver, P.; Cucchiarini, A.; Guédin, A.; Mergny, J.L.; Rosu, F.; Gabelica, V.; Freccero, M.; Doria, F.; et al. Thiosugar naphthalene diimide conjugates: G-quadruplex ligands with antiparasitic and anticancer activity. Eur. J. Med. Chem. 2022,232, 114183. [CrossRef] 56. Ceccherini, V.; Giorgi, E.; Mannelli, M.; Cirri, D.; Gamberi, T.; Gabbiani, C.; Pratesi, A. Synthesis, chemical characterization, and biological evaluation of hydrophilic gold(I) and silver(I) N-heterocyclic carbenes as potential anticancer agents. Inorg. Chem. 2024, 63, 16949–16963. [CrossRef] 57. Ryzhakov, D.; Beillard, A.; Le Bideau, F.; Al-Shuaeeb, R.A.A.; Alami, M.; Bantreil, X.; Bonnemoy, A.; Gautier, A.; Lamaty, F.; Messaoudi, S. Azoliums and Ag(I)-N-heterocyclic carbene thioglycosides: Synthesis, reactivity and bioactivity. Eur. J. Org. Chem. 2022,2022, e202101499. [CrossRef] 58. Cristófalo, A.E.; Cagnoni, A.J.; Uhrig, M.L. Synthesis of N-acetylglucosamine and N-acetylallosamine resorcinarene-based multivalent β -thio-glycoclusters: Unexpected affinity of N-acetylallosamine ligands towards wheat germ agglutinin. Org. Biomol. Chem. 2020,18, 6853–6865. [CrossRef] 59. Hopkinson, M.N.; Richter, C.; Schedler, M.; Glorius, F. An Overview of N-heterocyclic carbenes. Nature 2014,510, 485–496. [CrossRef] 60. Shit, P.; Kundu, M.; Misra, A.K. Straightforward stereoselective synthesis of 1-thioβ -D-mannosides and 1-thioβ -L-rhamnosides. Tetrahedron Lett. 2023,118, 154391. [CrossRef] 61. Csávás, M.; Eszenyi, D.; Mez˝o, E.; Lázár, L.; Debreczeni, N.; Tóth, M.; Somsák, L.; Borbás, A. Stereoselective synthesis of carbon-sulfur-bridged glycomimetics by photoinitiated thiol-ene coupling reactions. Int. J. Mol. Sci. 2020,21, 573. [CrossRef] 62. Reintjens, N.R.M.; Witte, M.D.; Minnaard, A.J. Site-selective introduction of thiols in unprotected glycosides. Org. Biomol. Chem. 2023,21, 5098–5103. [CrossRef] [PubMed] 63. Kern, M.K.; Pohl, N.L.B. Automated solution-phase synthesis of S-glycosides for the production of oligomannopyranoside derivatives. Org. Lett. 2020,22, 4156–4159. [CrossRef] [PubMed] 64. Meena; Sam, M.; Pierce, K.; Szostak, J.W.; McLaughlin, L.W. 2 ′ ,3 ′ -Dideoxy-3 ′ -thionucleoside triphosphates: Syntheses and polymerase substrate activities. Org. Lett. 2007,9, 1161–1163. [CrossRef] 65. Zargar, I.A.; Sakander, N.; Mukherjee, D. 2-Ketophenyl assisted biomimetic synthesis of 3-thio substituted glycals at room temperature. Eur. J. Org. Chem. 2023,26, e202300780. [CrossRef] 66. Liu, Y.; Jiao, Y.; Luo, H.; Huang, N.; Lai, M.; Zou, K.; Yao, H. Catalyst-controlled regiodivergent synthesis of 1and 3-thiosugars with high stereoselectivity and chemoselectivity. ACS Catal. 2021,11, 5287–5293. [CrossRef] 67. Qin, K.; Zhang, H.; Zhao, Z.; Chen, X. Protein S-glyco-modification through an elimination–addition mechanism. J. Am. Chem. Soc. 2020,142, 9382–9388. [CrossRef] 68. Shit, P.; Kundu, M.; Misra, A.K. Expeditious preparation of 1,6-anhydro-1-thioβ -D-hexopyranose derivatives. Carbohydr. Res. 2023,525, 108765. [CrossRef] Molecules 2025,30, 2053 50 of 54 69. Kundu, M.; Misra, A.K. Direct synthesis of unsymmetrical glycosyl disulfides from glycosyl bromides. Eur. J. Org. Chem. 2021, 2021, 3759–3767. [CrossRef] 70. Anghinoni, J.M.; Birmann, P.T.; da Rocha, M.J.; Gomes, C.S.; Davies, M.J.; Brüning, C.A.; Savegnago, L.; Lenardão, E.J. Recent advances in the synthesis and antioxidant activity of low molecular mass organoselenium molecules. Molecules 2023,28, 7349. [CrossRef] 71. Jain, V.K.; Priyadarsini, K.I. Selenium compounds as promising antiviral agents. New J. Chem. 2024,48, 6534–6552. [CrossRef] 72. Ibáñez-Escribano, A.; Fonseca-Berzal, C.; Martínez-Montiel, M.; Álvarez-Márquez, M.; Gómez-Núñez, M.; Lacueva-Arnedo, M.; Espinosa-Buitrago, T.; Martín-Pérez, T.; Escario, J.A.; Merino-Montiel, P.; et al. Thioand selenosemicarbazones as antiprotozoal agents against Trypanosoma cruzi and Trichomonas vaginalis.J. Enzyme Inhib. Med. Chem. 2022,37, 781–791. [CrossRef] [PubMed] 73. Pyka, P.; Garbo, S.; Fioravanti, R.; Jacob, C.; Hittinger, M.; Handzlik, J.; Zwergel, C.; Battistelli, C. Selenium-containing compounds: A new hope for innovative treatments in Alzheimer’s disease and Parkinson’s disease. Drug Discov. Today 2024,29, 104062. [CrossRef] [PubMed] 74. Velueta-Viveros, M.; Martínez-Bailén, M.; Puerta, A.; Romero-Hernández, L.L.; Kˇren, V.; Merino-Montiel, P.; Montiel-Smith, S.; Fernandes, M.X.; Moreno-Vargas, A.J.; Padrón, J.M.; et al. Carbohydrate-derived bicyclic selenazolines as new dual inhibitors (cholinesterases/OGA) against Alzheimer’s disease. Bioorg. Chem. 2022,127, 105983. [CrossRef] [PubMed] 75. Roldán-Peña, J.M.; Alejandre-Ramos, D.; López, Ó.; Maya, I.; Lagunes, I.; Padrón, J.M.; Peña-Altamira, L.E.; Bartolini, M.; Monti, B.; Bolognesi, M.L.; et al. New tacrine dimers with antioxidant linkers as dual drugs: Anti-Alzheimer’s and antiproliferative agents. Eur. J. Med. Chem. 2017,138, 761–773. [CrossRef] 76. Roldán-Peña, J.M.; Puerta, A.; Dini´c, J.; Stojanov, S.J.; González-Bakker, A.; Hicke, F.J.; Mishra, A.; Piyasaengthong, A.; Maya, I.; Walton, J.W.; et al. Biotinylated selenocyanates: Potent and selective cytostatic agents. Bioorg. Chem. 2023,133, 106410. [CrossRef] 77. Begines, P.; Martos, S.; Lagunes, I.; Maya, I.; Padrón, J.M.; López, Ó.; Fernández-Bolaños, J.G. Chemoselective preparation of new families of phenolic-organoselenium hybrids-a biological assessment. Molecules 2022,27, 1315. [CrossRef] 78. Ramos-Inza, S.; Plano, D.; Sanmartín, C. Metal-based compounds containing selenium: An appealing approach towards novel therapeutic drugs with anticancer and antimicrobial effects. Eur. J. Med. Chem. 2022,244, 114834. [CrossRef] 79. Begines, P.; Sevilla-Horrillo, L.; Puerta, A.; Puckett, R.; Bayort, S.; Lagunes, I.; Maya, I.; Padrón, J.M.; López, Ó.; FernándezBolaños, J.G. Masked phenolic-selenium conjugates: Potent and selective antiproliferative agents overcoming P-gp resistance. Pharmaceuticals 2020,13, 358. [CrossRef] 80. Lagunes, I.; Begines, P.; Silva, A.; Galán, A.R.; Puerta, A.; Fernandes, M.X.; Maya, I.; Fernández-Bolaños, J.G.; López, Ó.; Padrón, J.M. Selenocoumarins as new multitarget antiproliferative agents: Synthesis, biological evaluation and in silico calculations. Eur. J. Med. Chem. 2019,179, 493–501. [CrossRef] 81. Blumberg, K.; Fuccello, A.; van Es, T. Selenium derivatives of L-arabinose, D-ribose, and D-xylose. Carbohydr. Res. 1977,59, 351–362. [CrossRef] 82. Lucas, M.A.; Nguyen, O.T.K.; Schiesser, C.H.; Zheng, S.-L. Preparation of 5-selenopentopyranose sugars from pentose starting materials by samarium(II) iodide or (phenylseleno)formate mediated ring closures. Tetrahedron 2000,56, 3995–4000. [CrossRef] 83. Schiesser, C.H. The quest for selenocycles: From an ESR spectrum to a commercial product. J. Chem. Res. 2022,46. [CrossRef] 84. Liu, H.; Pinto, M.B. Synthesis of zwitterionic selenonium and sulfonium sulfates from D-mannose as potential glycosidase inhibitors. Can. J. Chem. 2006,84, 497–505. [CrossRef] 85. Schiesser, C.H.; Storkey, C.; Davies, M.J. Seleno-compounds and therapeutic uses thereof. U.S. Patent 2015/0191446 A1, 24 July 2014. 86. Merino-Montiel, P.; López, Ó.; Fernández-Bolaños, J.G. L-Isofucoselenofagomine and derivatives: Dual activities as antioxidants and as glycosidase inhibitors. Tetrahedron 2012,68, 3591–3595. [CrossRef] 87. Davies, M.J.; Schiesser, C.H. 1,4-Anhydro-4-seleno-D-talitol (SeTal): A remarkable selenium-containing therapeutic molecule. New J. Chem. 2019,43, 9759–9765. [CrossRef] 88. Zacharias, T.; Flouda, K.; Jepps, T.A.; Gammelgaard, B.; Schiesser, C.H.; Davies, M.J. Effects of a novel selenium substituted-sugar (1,4-anhydro-4-seleno-D-talitol, SeTal) on human coronary artery cell lines and mouse aortic rings. Biochem. Pharmacol. 2020, 173, 113631. [CrossRef] 89. Voss, G.T.; de Oliveira, R.L.; Davies, M.J.; Domingues, W.B.; Campos, V.F.; Soares, M.P.; Luchese, C.; Schiesser, C.H.; Wilhelm, E.A. Suppressive effect of 1,4-anhydro-4-seleno-D-talitol (SeTal) on atopic dermatitis-like skin lesions in mice through regulation of inflammatory mediators. J. Trace Elem. Med. Biol. 2021,67, 126795. [CrossRef] 90. Voss, G.T.; Davies, M.J.; Schiesser, C.H.; de Oliveira, R.L.; Nornberg, A.B.; Soares, V.R.; Barcellos, A.M.; Luchese, C.; Fajardo, A.R.; Wilhelm, E.A. Treating atopic-dermatitis-like skin lesions in mice with gelatin-alginate films containing 1,4-anhydro-4-seleno-Dtalitol (SeTal). Int. J. Pharm. 2023,642, 123174. [CrossRef] 91. di Vito, R.; Acito, M.; Fatigoni, C.; Schiesser, C.H.; Davies, M.J.; Mangiavacchi, F.; Villarini, M.; Santi, C.; Moretti, M. Genotoxicity assessment of 1,4-anhydro-4-seleno-D-talitol (SeTal) in human liver HepG2 and HepaRG cells. Toxicology 2023,499, 153663. [CrossRef] Molecules 2025,30, 2053 51 of 54 92. Iwaoka, M.; Takahashi, T.; Tomoda, S. Syntheses and structural characterization of water-soluble selenium reagents for the redox control of protein disulfide bonds. Heteroat. Chem. 2001,12, 293–299. [CrossRef] 93. Arai, K.; Kumakura, F.; Takahira, M.; Sekiyama, N.; Kuroda, N.; Suzuki, T.; Iwaoka, M. Effects of ring size and polar functional groups on the glutathione peroxidase-like antioxidant activity of water-soluble cyclic selenides. J. Org. Chem. 2015,80, 5633–5642. [CrossRef] [PubMed] 94. Singh, B.G.; Kumar, P.; Phadnis, P.; Iwaoka, M.; Priyadarsini, K.I. Free radical induced selenoxide formation in isomeric organoselenium compounds: The effect of chemical structures on antioxidant activity. New J. Chem. 2019,43, 13357–13362. [CrossRef] 95. Arai, K.; Tashiro, A.; Osaka, Y.; Iwaoka, M. Glutathione peroxidase-like activity of amino-substituted water-soluble cyclic selenides: A shift of the major catalytic cycle in methanol. Molecules 2017,22, 354. [CrossRef] [PubMed] 96. Kunwar, A.; Verma, P.; Bhilwade, H.N.; Iwaoka, M.; Priyadarsini, K.I. Dihydroxyselenolane (DHS) supplementation improves survivalfollowing whole-body irradiation (WBI) by suppressing tissue-specificinflammatory responses. Mutat. Res. 2016, 807, 33–46. [CrossRef] 97. Verma, P.; Kunwar, A.; Arai, K.; Iwaoka, M.; Priyadarsini, K.I. Mechanism of radioprotection by dihydroxy-1-selenolane (DHS): Effect of fatty acid conjugation and role of glutathione peroxidase (GPx). Biochimie 2018,144, 122–133. [CrossRef] 98. Iwaoka, M.; Sano, N.; Lin, Y.-Y.; Katakura, A.; Noguchi, M.; Takahashi, K.; Kumakura, F.; Arai, K.; Singh, B.G.; Kunwar, A.; et al. Fatty acid conjugates of water-soluble ( ± )-trans-selenolane-3,4-diol: Effects of alkyl chain length on the antioxidant capacity. ChemBioChem 2015,16, 1226–1234. [CrossRef] 99. Arai, K.; Sato, Y.; Nakajima, I.; Saito, M.; Sasaki, M.; Kanamori, A.; Iwaoka, M. Glutathione peroxidase-like functions of 1,2diselenane-4,5-diol and its amphiphilic derivatives: Switchable catalytic cycles depending on peroxide substrates. Bioorg. Med. Chem. 2021,29, 115866. [CrossRef] 100. Arai, K.; Ueno, H.; Asano, Y.; Chakrabarty, G.; Shimodaira, S.; Mugesh, G.; Iwaoka, M. Protein folding in the presence of water-soluble cyclic diselenides with novel oxidoreductase and isomerase activities. ChemBioChem 2018,19, 207–211. [CrossRef] 101. Iwaoka, M.; Katakura, A.; Mishima, J.; Ishihara, Y.; Kunwar, A.; Priyadarsini, K.I. Mimicking the lipid peroxidation inhibitory activity of phospholipid hydroperoxide glutathione peroxidase (GPx4) by using fatty acid conjugates of a water-soluble selenolane. Molecules 2015,20, 12364–12375. [CrossRef] 102. Chakrabarty, G.; NaveenKumar, S.K.; Kumar, S.; Mugesh, G. Modulation of redox signaling and thiol homeostasis in red blood cells by peroxiredoxin mimetics. ACS Chem. Biol. 2020,15, 2673–2682. [CrossRef] 103. Cimmino, G.; De Nisco, M.; Piccolella, S.; Gravina, C.; Pedatella, S.; Pacifico, S. Innovative cosmeceutical ingredients: Harnessing selenosugar-linked hydroxycinnamic acids for antioxidant and wound-healing properties. Antioxidants 2024,13, 744. [CrossRef] [PubMed] 104. Serpico, L.; De Nisco, M.; Cermola, F.; Manfra, M.; Pedatella, S. Stereoselective synthesis of selenium-containing glycoconjugates via the Mitsunobu reaction. Molecules 2021,26, 2541. [CrossRef] [PubMed] 105. Serpico, L.; Iacono, S.D.; De Stefano, L.; De Martino, S.; Battisti, M.; Dardano, P.; Pedatella, S.; De Nisco, M. pH-sensitive release of antioxidant Se-glycoconjugates through a flexible polymeric patch. Eur. Polym. J. 2022,178, 111486. [CrossRef] 106. Zhang, L.-X.; Li, C.-X.; Kakar, M.U.; Khan, M.S.; Wu, P.-F.; Amir, R.M.; Dai, D.-F.; Naveed, M.; Li, Q.-Y.; Saeed, M.; et al. Resveratrol (RV): A pharmacological review and call for further research. Biomed. Pharmacother. 2021,143, 112164. [CrossRef] 107. Cimmino, G.; De Nisco, M.; Alonso, C.; Gravina, C.; Piscopo, V.; Lemos, R.; Coderch, L.; Piccolella, S.; Pacifico, S.; Pedatella, S. Novel synthesized seleno-glycoconjugates as cosmeceutical ingredients: Antioxidant activity and in vitro skin permeation. Eur. J. Med. Chem. Rep. 2024,12, 100240. [CrossRef] 108. Iwaoka, M.; Hiyoshi, Y.; Arai, S.; Ito, T. Synthesis of 4-selenothreofuranose derivatives via Pummerer-type reactions of trans-3,4dioxygenated tetrahydroselenophenes mediated by a selenonium intermediate. ACS Omega 2021,6, 17621–17634. [CrossRef] 109. Lee, H.; Jarhad, D.B.; Yu, J.; Lee, C.; Jeong, L.S. Asymmetric synthesis of 2-C-methyl-4-selenonucleosides as anti-hepatitis C virus agents. J. Org. Chem. 2019,84, 14414–14426. [CrossRef] 110. Jeong, L.S.; Tosh, D.K.; Kim, H.O.; Wang, T.; Hou, X.; Yun, H.S.; Kwon, Y.; Lee, S.K.; Choi, J.; Zhao, L.X. First synthesis of 4-selenonucleosides showing unusual southern conformation. Org. Lett. 2008,10, 209–212. [CrossRef] 111. Okano, Y.; Saito-Tarashima, N.; Kurosawa, M.; Iwabu, A.; Ota, M.; Watanabe, T.; Kato, F.; Hishiki, T.; Fujimuro, M.; Minakawa, N. Synthesis and biological evaluation of novel imidazole nucleosides as potential anti-dengue virus agents. Bioorg. Med. Chem. 2019,27, 2181–2186. [CrossRef] 112. Sahu, P.K.; Kim, G.; Yu, J.; Ahn, J.Y.; Song, J.; Choi, Y.; Jin, X.; Kim, J.-H.; Lee, S.K.; Park, S.; et al. Stereoselective synthesis of 4-selenonucleosides via seleno-Michael reaction as potent antiviral agents. Org. Lett. 2014,16, 5796–5799. [CrossRef] 113. Yu, J.; Kim, J.-H.; Lee, H.W.; Alexander, V.; Ahn, H.-C.; Choi, W.J.; Choi, J.; Jeong, L.S. New RNA purine building blocks, 4 ′ - selenopurine nucleosides: First synthesis and unusual mixture of sugar puckerings. Chem. Eur. J. 2013,19, 5528–5532. [CrossRef] [PubMed] Molecules 2025,30, 2053 52 of 54 114. Yu, J.; Kim, J.W.; Chandra, G.; Saito–Tarashima, N.; Nogi, Y.; Ota, M.; Minakawa, N.; Jeong, L.S. Synthesis of oligonucleotides containing 5-homo-4-selenouridine derivative and its increased resistance against nuclease. Bioorg. Med. Chem. Lett. 2023, 83, 129172. [CrossRef] [PubMed] 115. Ota, M.; Takahashi, H.; Nogi, Y.; Kagotani, Y.; Saito-Tarashima, N.; Kondo, J.; Minakawa, N. Synthesis and properties of fully-modified 4-selenoRNA, an endonuclease-resistant RNA analog. Bioorg. Med. Chem. 2022,76, 117093. [CrossRef] 116. Kim, J.-H.; Yu, J.; Alexander, V.; Choi, J.H.; Song, J.; Lee, H.W.; Kim, H.O.; Choi, J.; Lee, S.K.; Jeong, L.S. Structure-activity relationships of 2 ′ -modified-4 ′ -selenoarabinofuranosyl-pyrimidines as anticancer agents. Eur. J. Med. Chem. 2014,83, 208–225. [CrossRef] 117. Byun, W.S.; Jin, M.; Yu, J.; Kim, W.K.; Song, J.; Chung, H.-J.; Jeong, L.S.; Lee, S.K. A novel selenonucleoside suppresses tumor growth by targeting Skp2 degradation in paclitaxel-resistant prostate cancer. Biochem. Pharmacol. 2018,158, 84–94. [CrossRef] 118. Chinetti, G.; Fruchart, J.-C.; Staels, B. Peroxisome proliferator-activated receptors (PPARs): Nuclear receptors at the crossroads between lipid metabolism and inflammation. Inflamm. Res. 2000,49, 497–505. [CrossRef] 119. An, S.; Yu, J.; Choi, H.; Ko, H.; Ahn, S.; Shin, J.C.; Pyo, J.J.; Jeong, L.S.; Noh, M. Selenium bioisosteric replacement of adenosine derivatives promoting adiponectin secretion increases the binding affinity to peroxisome proliferator-activated receptor δ .Bioorg. Med. Chem. 2020,28, 115226. [CrossRef] 120. Choi, H.; An, S.; Hyun, Y.E.; Noh, M.; Jeong, L.S. Design, synthesis and biological evaluation of truncated 1 ′ -homologated 4′-selenonucleosides as PPAR γ/δdual modulators. Bioorg. Chem. 2025,154, 108042. [CrossRef] 121. Yu, J.; Zhao, L.X.; Park, J.; Lee, H.W.; Sahu, P.K.; Cui, M.; Moss, S.M.; Hammes, E.; Warnick, E.; Gao, Z.-G.; et al. N 6 -Substituted 5-N-methylcarbamoyl-4-selenoadenosines as potent and selective A 3 adenosine receptor agonists with unusual sugar puckering and nucleobase orientation. J. Med. Chem. 2017,60, 3422–3437. [CrossRef] 122. Kim, M.; Choi, H.; Nayak, A.; Tripathi, S.K.; Aswar, V.R.; Gaikwad, V.B.; Jacobson, K.A.; Jeong, L.S. Structure − activity relationship of truncated 4-selenonucleosides: A 3 adenosine receptor activity and binding selectivity. ACS Med. Chem. Lett. 2024,15, 1620–1626. [CrossRef] 123. Choi, H.; Jacobson, K.A.; Yu, J.; Jeong, L.S. Design and synthesis of 2,6-disubstituted-4 ′ -selenoadenosine-5 ′ -N,Ndimethyluronamide derivatives as human A 3 adenosine receptor antagonists. Pharmaceuticals 2021,14, 363. [CrossRef] [PubMed] 124. Raics, M.; Timári, I.; Diercks, T.; Szilágyi, L.; Gabius, H.-J.; Kövér, K.E. Selenoglycosides as lectin ligands: 77 Se-edited CPMGHSQMBC NMR spectroscopy to monitor biomedically relevant interactions. ChemBioChem 2019,20, 1688–1692. [CrossRef] [PubMed] 125. Suzuki, T.; Hayashi, C.; Komura, N.; Tamai, R.; Uzawa, J.; Ogawa, J.; Tanaka, H.-N.; Imamura, A.; Ishida, H.; Kiso, M.; et al. Synthesis and glycan − protein interaction studies of Se-sialosides by 77 Se NMR. Org. Lett. 2019,21, 6393–6396. [CrossRef] [PubMed] 126. Diercks, T.; Medrano, F.J.; FitzGerald, F.G.; Beckwith, D.; Pedersen, M.J.; Reihill, M.; Ludwig, A.-K.; Romero, A.; Oscarson, S.; Cudic, M.; et al. Galectin–glycan interactions: Guidelines for monitoring by 77 Se NMR spectroscopy, and solvent (H 2 O/D 2 O) impact on binding. Chem. Eur. J. 2021,27, 316–325. [CrossRef] 127. Raics, M.; Balogh, A.K.; Kishor, C.; Timári, I.; Medrano, F.J.; Romero, A.; Go, R.M.; Blanchard, H.; Szilágyi, L.; Kövér, K.E.; et al. Investigation of the molecular details of the interactions of selenoglycosides and human galectin-3. Int. J. Mol. Sci. 2022,23, 2494. [CrossRef] 128. Dibello, E.; Oddone, N.; Franco, J.; Illyés, T.-Z.; Medeiros, A.; Kiss, A.; H˝ogye, F.; Kövér, K.E.; Szilágyi, L.; Comini, M.A. Selenosugars targeting the infective stage of Trypanosoma brucei with high selectivity. Int. J. Parasitol. Drugs Drug Resist. 2024, 24, 100529. [CrossRef] 129. McDonagh, A.W.; Mahon, M.F.; Murphy, P.V. Lewis acid induced anomerization of Se-glycosides. Application to synthesis of α-Se-GalCer. Org. Lett. 2016,18, 552–555. [CrossRef] 130. Zhu, M.; Alami, M.; Messaoudi, S. Room-temperature Pd-catalyzed synthesis of 1-(hetero)aryl selenoglycosides. Org. Lett. 2020, 22, 6584–6589. [CrossRef] 131. Ding, Y.-N.; Huang, Y.-C.; Shi, W.-Y.; Zheng, N.; Wang, C.-T.; Chen, X.; An, Y.; Zhang, Z.; Liang, Y.-M. Modular synthesis of aryl thio/selenoglycosides via the Catellani strategy. Org. Lett. 2021,23, 5641–5646. [CrossRef] 132. Catellani, M.; Frignani, F.; Rangoni, A. A complex catalytic cycle leading to a regioselective synthesis of o,o ′ -disubstituted vinylarenes. Angew. Chem. Int. Ed. Engl. 1997,36, 119–122. [CrossRef] 133. Azeem, Z.; Mandal, P.K. Atom-economic synthesis of unsymmetrical gem-diarylmethylthio/seleno glycosides via base mediated C(O) − S/Se bond cleavage and acyl transfer approach of glycosylthio/selenoacetates. J. Org. Chem. 2023,88, 1695–1712. [CrossRef] [PubMed] 134. Shit, P.; Sahaji, S.; Misra, A.K. Synthesis of selenoglycosides and selenium linked disaccharides using reductive cleavage of diselenides. Carbohydr. Res. 2022,516, 108554. [CrossRef] [PubMed] Molecules 2025,30, 2053 53 of 54 135. Romanò, C.; Bengtsson, D.; Infantino, A.S.; Oscarson, S. Synthesis of fluoroand seleno-containing D-lactose and D-galactose analogues. Org. Biomol. Chem. 2023,21, 2545–2555. [CrossRef] [PubMed] 136. Manna, T.; Misra, A.K. Glycosyl selenoacetates: Versatile building blocks for the preparation of stereoselective selenoglycosides and selenium linked disaccharides. Org. Biomol. Chem. 2019,17, 8902–8912. [CrossRef] 137. Angeli, A.; Ferraroni, M.; Granchi, C.; Minutolo, F.; Chen, X.; Shriwas, P.; Russo, E.; Leo, A.; Selleri, S.; Carta, F.; et al. First-in-class dual targeting compounds for the management of seizures in glucose transporter type 1 deficiency syndrome. J. Med. Chem. 2023, 66, 10010–10026. [CrossRef] 138. Ma, T.; Li, C.; Liang, H.; Wang, Z.; Yu, L.; Xue, W. InBr 3 -catalyzed synthesis of aryl 1,2-trans-thio(seleno)glycosides. Synlett 2017, 28, 2311–2314. [CrossRef] 139. Fomitskaya, P.A.; Argunov, D.A.; Tsvetkov, Y.E.; Lalov, A.V.; Ustyuzhanina, N.E.; Nifantiev, N.E. Further investigation of the 2-azido-phenylselenylation of glycals. Eur. J. Org. Chem. 2021,2021, 5897–5904. [CrossRef] 140. Guberman, M.; Pieber, B.; Seeberger, P.H. Safe and scalable continuous flow azidophenylselenylation of galactal to prepare galactosamine building blocks. Org. Process Res. Dev. 2019,23, 2764–2770. [CrossRef] 141. Zhu, F.; O’Neill, S.; Rodriguez, J.; Walczak, M.A. Stereoretentive reactions at the anomeric position: Synthesis of selenoglycosides. Angew. Chem. Int. Ed. 2018,57, 7091–7095. [CrossRef] 142. Miller, E.M.; Walczak, M.A. Light-mediated cross-coupling of anomeric trifluoroborates. Org. Lett. 2021,23, 4289–4293. [CrossRef] 143. Compañón, I.; Guerreiro, A.; Mangini, V.; Castro-López, J.; Escudero-Casao, M.; Avenoza, A.; Busto, J.H.; Castillón, S.; JiménezBarbero, J.; Asensio, J.L.; et al. Structure-based design of potent tumor-associated antigens: Modulation of peptide presentation by single-atom O/S or O/Se substitutions at the glycosidic linkage. J. Am. Chem. Soc. 2019,141, 4063–4072. [CrossRef] [PubMed] 144. Kazakova, E.D.; Yashunsky, D.V.; Krylov, V.B.; Bouchara, J.-P.; Cornet, M.; Valsecchi, I.; Fontaine, T.; Latgé, J.-P.; Nifantiev, N.E. Biotinylated oligoα -(1 → 4)-D-galactosamines and their N-acetylated derivatives: α -stereoselective synthesis and immunology application. J. Am. Chem. Soc. 2020,142, 1175–1179. [CrossRef] [PubMed] 145. Tokatly, A.I.; Vinnitsky, D.Z.; Kamneva, A.A.; Yashunsky, D.V.; Tsvetkov, Y.E.; Nifantiev, N.E. Glycosylation with derivatives of phenyl 2-azido-2-deoxy-1-seleno-α-D-glucoand -α-D-mannopyranosides. Russ. Chem. Bull. 2023,72, 785–792. [CrossRef] 146. Li, D.; Wang, J.; Wang, X.; Qiao, Z.; Wang, L.; Wang, P.; Song, N.; Li, M. β -Glycosylations with 2-deoxy-2-(2,4dinitrobenzenesulfonyl)-amino-glucosyl/galactosyl selenoglycosides: Assembly of partially N-acetylated β -(1 → 6)- oligoglucosaminosides. J. Org. Chem. 2023,88, 9004–9025. [CrossRef] 147. Li, X.; Hou, Y.; Zhao, J.; Li, J.; Wang, S.; Fang, J. Combination of chemotherapy and oxidative stress to enhance cancer cell apoptosis. Chem. Sci. 2020,11, 3215–3222. [CrossRef] 148. Manna, T.; Misra, A.K. On-water synthesis of glycosyl selenocyanate derivatives and their application in the metal free organocatalytic preparation of nonglycosidic selenium linked pseudodisaccharide derivatives. RSC Adv. 2021,11, 10902–10911. [CrossRef] 149. Manna, T.; Rana, A.; Misra, A.K. Synthesis of unsymmetrical glycosyl diselenides by the treatment of symmetrical diselenides with glycosyl selenocyanates. Tetrahedron 2021,95, 132358. [CrossRef] 150. Rana, A.; Kundu, M.; Misra, A.K. Convenient synthesis of mixed S-Se-linked pseudodisaccharides by sulfur and selenium exchange. Tetrahedron 2022,115, 132804. [CrossRef] 151. Wang, L.; Cao, W.; Xu, H. Tellurium-containing polymers: Towards biomaterials and optoelectronic materials. ChemNanoMat 2016,2, 479–488. [CrossRef] 152. Comasseto, J.V.; Barrientos-Astigarraga, R.E. Add a little tellurium to your synthetic plans! Aldrichimica Acta 2000,33, 66–78. 153. Irfan, M.; Rehman, R.; Razali, M.R.; Ur-Rehman, S.; Ur-Rehman, A.; Iqbal, M.A. Organotellurium compounds: An overview of synthetic methodologies. Rev. Inorg. Chem. 2020,40, 193–232. [CrossRef] 154. Jain, S.; Satpute, S.S.; Jha, R.K.; Patel, M.S.; Kumar, S. Bidentate ligand driven intramolecularly Te . . . O bonded organotellurium cations from synthesis, stability to catalysis. Chem. Eur. J. 2024,30, e202303089. [CrossRef] [PubMed] 155. Purohit, S.; Oswal, P.; Bahuguna, A.; Tyagi, A.; Bhatt, N.; Kumar, A. Catalytic system having an organotellurium ligand on graphene oxide: Immobilization of Pd(0) nanoparticles and application in heterogeneous catalysis of cross-coupling reactions. RSC Adv. 2024,14, 27092–27109. [CrossRef] 156. Comasseto, J.V.; Gariani, R.A. Biotransformations on organic selenides and tellurides: Synthetic applications. Tetrahedron 2009,65, 8447–8459. [CrossRef] 157. Zhao, H.; Xu, X.; Zhang, S.; Sun, J.; He, W.; Zhang, L.; Cheng, Z. NIR Photocontrolled organotellurium-mediated reversibledeactivation radical polymerization by activation of C–Te bonds with organotellurium radicals. Macromolecules 2024,57, 1182–1194. [CrossRef] 158. Takagi, K.; Hayashi, S.; Sakakibara, N. Controlled cationic polymerization with organotellurium catalysts utilizing redox-mediated chalcogen bonding interaction. Macromolecules 2024,57, 3358–13367. [CrossRef] 159. Jiang, Y.; Kibune, M.; Tosaka, M.; Yamago, S. Practical synthesis of dendritic hyperbranched polyacrylates and their topological block polymers by organotellurium-mediated emulsion polymerization in water. Angew. Chem. Int. Ed. 2023,62, e202306916. [CrossRef] Molecules 2025,30, 2053 54 of 54 160. Bhardwaj, A.; Dubey, A.; Tufail, A.; Tufail, N.; Jangra, K.; Garg, S. Experimental and computational insights into organotellurium (IV) complexes as potent PfNDH2 inhibitors: Synthesis, characterization, and antimalarial evaluation. Appl. Organometal. Chem. 2025,39, e7778. [CrossRef] 161. Angeli, A.; Pinteala, M.; Maier, S.S.; Toti, A.; Mannelli, L.D.C.; Ghelardini, C.; Selleri, S.; Carta, F.; Supuran, C.T. Tellurides bearing benzensulfonamide as carbonic anhydrase inhibitors with potent antitumor activity. Bioorg. Med. Chem. Lett. 2021,45, 128147. [CrossRef] 162. Wollenhaupt, S.G.N.; Soares, A.T.; Salgueiro, W.G.; Noremberg, S.; Reis, G.; Viana, C.; Gubert, P.; Soares, F.A.; Affeldt, R.F.; Lüdtke, D.S.; et al. Selenoand telluro-xylofuranosides attenuate Mn-induced toxicity in C. elegans via the DAF-16/FOXO pathway. Food Chem. Toxicol. 2014,64, 192–199. [CrossRef] 163. Jiao, A.; Yang, N.; Wang, J.; Xu, X.; Jin, Z. Cyclodextrin-derived chalcogenides as glutathione peroxidase mimics and their protection of mitochondria against oxidative damage. J. Incl. Phenom. Macrocycl. Chem. 2013,75, 155–163. [CrossRef] 164. Nguyen, O.T.K.; Schiesser, C.H. Preparation of 5-telluropentopyranose sugars from common pentose starting materials. Tetrahedron Lett. 2002,43, 3799–3800. [CrossRef] 165. Tanini, D.; Ricci, L.; Capperucci, A. Rongalite-promoted on water synthesis of functionalised tellurides and ditellurides. Adv. Synth. Catal. 2020,362, 1323–1332. [CrossRef] 166. Kashyap, C.; Mazumder, L.J.; Rohman, S.S.; Ullah, S.S.; Guha, A.K. Re-visiting the antioxidant activity of Seand Te-carbohydrates: A theoretical study. ChemistrySelect 2019,4, 1470–1475. [CrossRef] 167. Yamago, S.; Kokubo, K.; Masuda, S.; Yoshida, J.-i. Practical synthesis of telluroglycosides. Synlett 1996,1996, 929–930. [CrossRef] 168. Tsegay, S.; Williams, R.J.; Williams, S.J. Synthesis of glycosyl fluorides from thio-, seleno-, and telluroglycosides and glycosyl sulfoxides using aminodifluorosulfinium tetrafluoroborates. Carbohydr. Res. 2012,357, 16–22. [CrossRef] 169. Nagatomo, M.; Kamimura, D.; Matsui, Y.; Masuda, K.; Inoue, M. Et 3 B-mediated twoand three-component coupling reactions via radical decarbonylation of α -alkoxyacyl tellurides: Single-step construction of densely oxygenated carboskeletons. Chem. Sci. 2015,6, 2765–2769. [CrossRef] 170. Fukuda, T.; Nagatomo, M.; Inoue, M. Total synthesis of diospyrodin and its three diastereomers. Org. Lett. 2020,22, 6468–6472. [CrossRef] 171. Nagatomo, M.; Zhang, K.; Fujino, H.; Inoue, M. Et 3 B/Et 2 AlCl/O 2 -mediated radical coupling reaction between α -alkoxyacyl tellurides and 2-hydroxybenzaldehyde derivatives. Chem. Asian J. 2020,15, 3820–3824. [CrossRef] 172. Fujino, H.; Nagatomo, M.; Paudel, A.; Panthee, S.; Hamamoto, H.; Sekimizu, K.; Inoue, M. Unified total synthesis of polyoxins J, L, and fluorinated analogues on the basis of decarbonylative radical coupling reactions. Angew. Chem. Int. Ed. 2017,56, 11865–11869. [CrossRef] 173. Nagatomo, M.; Fujimoto, Y.; Masuda, K.; Inoue, M. Construction of a 6/5/9-membered tricyclic structure of cladiellins via radical-polar crossover reaction. J. Antibiot. 2019,72, 486–489. [CrossRef] [PubMed] 174. Kuwana, D.; Ovadia, B.; Kamimura, D.; Nagatomo, M.; Inoue, M. Installation of O-heterocycles to N-heteroarenes via an Et3B/O2-mediated radical reaction of α-alkoxy and α-alkoxyacyl tellurides. Asian J. Org. Chem. 2019,8, 1088–1091. [CrossRef] 175. Masuda, K.; Nagatomo, M.; Inoue, M. Direct assembly of multiply oxygenated carbon chains by decarbonylative radical–radical coupling reactions. Nat. Chem. 2017,9, 207–212. [CrossRef] [PubMed] 176. Kawamata, T.; Yamaguchi, A.; Nagatomo, M.; Inoue, M. Convergent total synthesis of asimicin via decarbonylative radical dimerization. Chem. Eur. J. 2018,24, 18907–18912. [CrossRef] Disclaimer/Publisher’s Note: The statements, opinions and data contained in all publications are solely those of the individual author(s) and contributor(s) and not of MDPI and/or the editor(s). MDPI and/or the editor(s) disclaim responsibility for any injury to people or property resulting from any ideas, methods, instructions or products referred to in the content.